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ABSTRACT 
 Adult neurogenesis occurs in two regions of the brain: the subventricular zone of 
lateral ventricles and the subgranular zone of hippocampus.  Neural progenitor cells found in 
these neurogenic regions are capable of self-renewing and generating mature neurons and 
glia.  It is known that reciprocal interactions with the local environment can regulate cellular 
maintenance and plasticity of neural progenitor cells.  Astrocytes in the microenvironment 
surrounding neural progenitor cells have a profound influence on a variety of inter- and intra-
cellular processes during adult neurogenesis.  Thus, we have investigated the roles of 
astrocyte-derived factors which influence neural progenitor cell differentiation in vitro.  The 
neural progenitor cells used in our studies were hippocampal progenitor cells isolated from 
adult rat hippocampus (a gift from F. Gage, Salk Institute, La Jolla, CA).   
Previous immunocytochemical results showed that co-culture with enriched neonatal 
astrocytes significantly and selectively increased neuronal differentiation of adult 
hippocampal progenitor cells.  We proposed that the astrocytes present discrete modulators to 
the overlying adult hippocampal progenitor cells involving contact-mediated or release of 
soluble factors, or a combination of both.  From the first investigation in this dissertation, we 
found that astrocyte-derived soluble factors specifically promote neuronal differentiation of 
neural progenitor cells.  In the second investigation, we tested a hypothesis that a candidate 
neurogenic factor produced from astrocytes, interleukin-6, is a key regulator that stimulates 
functional differentiation of neural progenitor cells to a neuronal fate.  Using 
immunocytochemical analysis and whole-cell recording, we have demonstrated that 
astrocyte-derived interleukin-6 enhances neuronal differentiation of AHPCs by presenting 
three main observations: (a) neuronal marker expression was increased, (b) the average 
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length of neurites from neuronal-restricted AHPCs was increased and (c) voltage-gated 
inward current density was increased with no significant differences in voltage-gated 
outward current density, apparent resting membrane potential, or cell capacitance.  In the 
third investigation, we examined the influence of extracellular calcium and voltage-gated 
calcium channel activity on interleukin-6-mediated neuronal differentiation of neural 
progenitor cells.  We observed that interleukin-6-enhanced neuronal differentiation was 
reduced when cultured in low calcium-containing culture medium or with L-type voltage-
gated calcium channel antagonists.  Interleukin-6 treatment also increased the fraction of 
neural progenitor cells immunoreactive for a neuronal marker and for cAMP response 
element binding protein.   
Overall, we conclude that astrocyte-derived soluble factors promote neuronal 
differentiation of adult neural progenitor cells, and astrocyte-derived interleukin-6 is a 
neurogenic factor able to induce neural progenitor cells to differentiate into neurons.  These 
findings may provide important insights into mechanisms for controlling neural progenitor 
cell differentiation and facilitate development of cell-based therapeutic strategies using adult 
neural progenitor cells.   
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CHAPTER 1.   
GENERAL IINTRODUCTION 
 
Introduction 
 The adult mammalian central nervous system can generate new neurons and glial 
cells from neural progenitor cells in a process known as adult neurogenesis
1, 2
.  Neural 
progenitor cells are known to reside in two regions in the brain: the subventricular zone along 
the wall of lateral ventricles, and the subgranular zone of the dentate gyrus of the 
hippocampus
3, 4
.  A variety of factors derived from local environment of neural progenitor 
cells can influence different stages of neurogenesis in the adult brain in vivo
5-9
.  Astrocytes 
are a prevalent cell type surrounding neural progenitor cells and possess region-specific 
characteristics.   
 The following chapters discuss astrocyte-derived soluble factors influencing 
differentiation of adult neural progenitor cells.  We have demonstrated that adult 
hippocampal progenitor cells favor differentiating into a neuronal lineage when cultured in 
the presence of soluble factors produced from hippocampal astrocytes (Chapter 2), and the 
cytokine interleukin-6 is an astrocyte-derived factor which specifically promotes neuronal 
differentiation of adult neural progenitor cells (Chapter 3).  In addition, we investigated 
possible mechanisms of interleukin-6-mediated neuronal differentiation in adult neural 
progenitor cells (Chapter 4).    
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Dissertation Organization 
This dissertation begins with a literature review (in Chapter 1) on adult neurogenesis, 
the neurogenic niche and neurogenesis-regulating factors.  
The body of this dissertation is composed of three chapters (Chapter 2, 3 and 4) based 
on the following three manuscripts published or in preparation to be submitted to peer-
reviewed international journals.   
 
Chapter 2: Soluble factors from neocortical astrocytes enhance neuronal 
differentiation of neural progenitor cells from adult rat hippocampus on 
micropatterned polymer substrates, by Jisun Oh, Jennifer B. Recknor, Justin C. 
Recknor, Surya K. Mallapragada and Donald S. Sakaguchi, published in Journal of 
Biomedical Materials Research Part A, 2009 Nov;91(2):575-585.  
 
Chapter 3: Astrocyte-derived interleukin-6 promotes specific neuronal 
differentiation of neural progenitor cells from adult hippocampus, by Jisun Oh, 
Michael A. McCloskey, Christopher C. Blong, Lee Bendickson, Marit Nilsen-
Hamilton and Donald S. Sakaguchi, published in Journal of Neuroscience Research, 
2010 Oct;88(13):2798-2809. 
 
Chapter 4: Effects of calcium influx on interleukin-6-mediated neuronal 
differentiation of adult neural progenitor cells, by Jisun Oh, Michael A. 
McCloskey, Michael Z. Khan, Senyo S. Whyte, Pavel A. Brodskiy and Donald S. 
Sakaguchi, in preparation.  
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Abbreviations 
[Ca]ext, extracellular calcium concentration 
[Ca]i, intracellular calcium concentration 
AraC, arabinosylcytosine  
Ba, barium  
BDNF, brain-derived neurotrophic factor 
bFGF, basic fibroblast growth factor or fibroblast growth factor-2 
bHLH, basic helix-loop-helix  
BMPs, bone morphogenetic proteins 
BrdU, bromodeoxyuridine  
Ca, calcium 
Cav channels, voltage-gated calcium channels 
CNS, central nervous system 
ECM, extracellular matrix 
EGF, epidermal growth factor 
ERK, extracellular signal-regulated kinase; also known as MAPK  
FBS, fetal bovine serum  
FGF, fibroblast growth factor  
Gadd45b, growth arrest and DNA-damage-inducible protein 45 beta 
GFAP, glial fibrillary acidic protein  
IL-6, interleukin-6  
IL-6R, interleukin-6-specific receptor 
JAKs, janus kinases  
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KCl, potassium chloride  
MAP2ab, microtubule associated protein 2ab  
MAPK, mitogen-activated protein kinase 
MBP, myelin basic protein  
MMP, matrix metalloproteases 
NG2, chondroitin sulfate proteoglycan  
NGF, nerve growth factor  
Ngn2, neurogenin 2  
NMDA, N-methyl-D-aspartic acid  
NPC, neural progenitor cells 
NT, neurotrophin 
PSA-NCAM, poly-sialated neural cell adhesion molecule  
RMS, rostral migratory stream  
SGZ, subgranular zone  
Shh, sonic hedgehog 
Sox, SRY (sex determining region Y)-related HMG (high-motility group) box 
STAT, signal transducer and activator of transcription 
SVZ, subventricular zone  
Tbr1, T-box transcription factor  
VEGF, vascular endothelial growth factor  
Wnt, wingless-related MMTV (mouse mammary tumor virus) integration site 
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Literature Review 
 
Adult neurogenesis  
Neurogenesis encompasses the whole process of generating new functional neurons 
from pluripotent stem cells or multipotent neural progenitor cells (NPCs).  In general, 
neurogenesis includes proliferation, survival, fate determination, and differentiation of NPCs 
as well as migration, functional maturation and integration of the progeny
1
.  Neurogenesis 
was previously believed to occur only during embryonic stages
2
.  Adult mammalian brains 
were considered to be postmitotic structures which do not produce or incorporate newborn 
cells after the conclusion of development
2,3
.   
However, using a method for detecting cell proliferation (incorporation of [H
3
]-
thymidine and autoradiography
4
), Smart (1961) reported for the first time the existence of 
actively dividing cells in the subependymal layer in the region of the lateral ventricles and 
their ability to migrate toward the periphery of the cortex in the neonatal mouse brain.  In the 
late 1960s, Altman and colleagues demonstrated that proliferating and migrating cells can be 
found in the hippocampus
5
 and olfactory bulb
6
 of the neonatal rat brain, using [H
3
]-thymidine 
labeling and histological analysis.  In 1977, Kaplan and colleagues reported findings 
consistent with those of Altman and colleagues but derived from an additional technique – 
electron microscopy.  Kaplan’s group found that new neurons were generated in the 
hippocampus and olfactory bulbs of the mature rodent (adult mouse and rat) brain and that 
some of newborn cells formed synapses
7-9
.  In the 1980’s, Nottebohm and colleagues 
demonstrated that new neurons were persistently added into the brain of adult songbirds 
during seasonal song learning
10-13
.  From a series of studies, they found that (a) generation of 
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new neurons in the adult songbird brain during seasonal song learning was regulated by 
seasonal changes in gonadal hormone levels, (b) only a subpopulation of newborn cells 
survived and integrated into the brain circuits, and (c) generation and integration of new 
neurons in the songbird brain were associated with learning new syllables.  Based on these 
results, Nottebohm and colleagues suggested four criteria to address the generation of new 
neurons in the adult brain as ‘adult neurogenesis’: (1) presence of newborn neurons derived 
from proliferating primitive cells (incorporating [H
3
]-thymidine), (2) morphological and 
phenotypical characteristics (displaying the appropriate neurite arborization and expressing 
neuronal markers), (3) electrophysiological membrane properties, and (4) connections with 
neighboring cells (forming synapses).   
In the 1990s, self-renewing and multipotent NPCs were isolated from the neurogenic 
regions of the mature rodent brain, propagated for various in vitro studies, and used for 
examining cell plasticity following transplantation
14-16
.  Accumulating evidence from in vitro 
and in vivo studies have demonstrated that NPCs exist in the brain of adult mammals, and 
continuous neurogenesis occurs in two specific areas of the adult brain throughout life
15,17-22
, 
(i) the subventricular zone (SVZ) lining the lateral ventricles and (ii) the subgranular zone 
(SGZ) of the dentate gyrus of the hippocampus.  Adult neurogenesis is widely accepted as a 
definite biological event which occurs in the SVZ and SGZ of the intact adult mammalian 
brain
23-25
.  The occurrence of adult neurogenesis in other brain regions, such as the amygdala, 
hypothalamus, substantia nigra, and striatum, remains disputed due to the lack of replicable 
evidence
26
.   
 
Adult neural progenitor cells in the subventricular zone 
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Adult NPCs can proliferate by generating more of themselves (self-renewal) and give 
rise to neural cells (i.e. neurons, oligodendrocytes, and astrocytes; multipotency)
18,22,27
.  The 
SVZ of the lateral ventricle wall is one of the neurogenic regions where NPCs are born in the 
adult rodent brain
23,28
.  Neuroblasts produced in the SVZ migrate toward the olfactory bulbs 
along the rostral migratory stream (RMS; in a unique way of ‘tangential chain migration’).  
Neuroblasts that migrated rostrally migrate further radially into the granule cell layer and 
glomerular layer in the olfactory bulbs
23
.  But almost all newborn cells in the olfactory bulbs 
differentiate into granule cells
29,30
.  Apical dendrites of newborn cells are extended and 
arborized, and form reciprocal synapses with the dendrites of mitral and tufted cells
28
.  
Functionally, newborn cells in the olfactory bulbs are known to be involved in maintenance 
of the structure of existing neural circuitry as well as in discrimination of odors
1,31
.   
The presence of a human RMS in the adult human brain is still debated
26,32
.  However, 
several reports discribe a population of proliferative cells exists in the SVZ
33
 and that 
migratory neuroblasts are present around a lateral ventricular extension reaching the 
olfactory bulb
34,35
.  Thus, it appears widely agreed that adult NPCs are present in the SVZ of 
the human brain, migratory neuroblasts are found in a rostral extension of the primary 
proliferative zone, and new neurons are generated in the adult human olfactory bulb.     
During adult neurogenesis in the SVZ, there are three types of precursor cells 
found
36,37
: (1) type B cells that are non-proliferative, and nestin- and GFAP-positive; (2) type 
C cells (transit amplifying cells) that are proliferative, and BrdU- and nestin-positive; and (3) 
type A cells (migrating neuroblasts) that are proliferative, and nestin- and doublecortin-
positive.  Type B cells have been defined as NPCs in the SVZ because of their ability to 
generate neurospheres and differentiated progeny in vitro
38
.  Type B cells are a subpopulation 
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of radial glia-derived astrocytes
39
 or ventricle-contacting ciliated ependymal cells (which is a 
final fate of radial glial cells)
38,40
.  However, these ependymal cells are quiescent and lack 
apparent self-renewal capacity under normal conditions; i.e. they are consumed when 
stimulated to produce their progeny
40,41
.  Therefore, quiescent ependymal cells are 
distinguished from NPCs even though they are multipotent.  Moreover, Mirzadeh et al. 
(2008) recently demonstrated that there are at least three types of ventricle-contacting cells 
along the ependyma according to their morphology
36
: (i) type B cells, which possess a single, 
short primary cilium; (ii) ependymal cells, which contain multiple long cilia encircling B 
cells (so-called E1 cells); and (iii) cells which often have two long cilia and a relatively larger 
surface area of the basal body facing the lateral ventricles (referred to as E2 cells).  In 
addition, these ventricle-contacting cells were all found to be quiescent in vivo unless they 
were activated
36
.  Therefore, it remains to be elucidated what kind of cells in the adult SVZ 
actually function as NPCs; whether they are capable of self-renewing as well as whether 
SVZ-derived newly generated neural cells are originating from a common NPC or from 
distinct progenitors for each cell type.  
 
Adult neural progenitor cells in the subgranular zone 
 In the SGZ of the dentate gyrus in the hippocampus, two types of NPCs have been 
identified according to their morphology and molecular phenotypes
42,43
: (1) type 1 cells, 
which have a radial process spanning the entire granule cell layer and ramifying in the inner 
molecular layer, and which are GFAP/nestin/Sox2-positive; (2) type 2 cells, which have 
multiple, short processes and are nestin/Sox2-positive but GFAP-negative.  Suspicions that 
actively self-renewing type 2 cells originate from quiescent or infrequently dividing type 1 
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cells
42
 are based mainly upon research by Seri et al. (2004)
44
 and Ahn and Joyner (2005)
45
.  
In these studies, they reported that (a) treatment with anti-mitotic drugs, such as AraC and/or 
procarbazol to eliminate fast-dividing cells, decreased the number of newborn cells in the 
SGZ of adult mice, and (b) in AraC-treated mice, rarely dividing GFAP-positive (type 1) 
cells survived, produced fast-dividing cells and differentiated into PSA-NCAM-positive 
granule neurons in the dentate gyrus.   
Recently, Suh et al. (2007) have studied different properties of two morphologically 
different mouse hippocampal NPCs using retrovirus-mediated fate-tracing
42
.  First, they 
found that Sox2-positive NPCs (including both types of hippocampal NPCs) were 
multipotent, able to give rise to granule neurons and astrocytes
42
.  Second, they showed that, 
after seven days of voluntary running (exercising is a mitotic signal), (a) the total number of 
Sox2-positive cells increased, (b) the number of Sox2-positive NPCs (which is a 
subpopulation of Sox2-postive cells in vivo) did not change, and (c) the number of 
doublecortin-positive neuronal precursors increased
42
.  These results demonstrated that 
hippocampal NPC pool size remains unchanged while certain cells acquire a potential to 
become proliferative or some cells in the pool differentiate into more mature cell types.    
Taken together, these findings suggest that type 1 cells may play an important role in 
maintaining the number of NPCs and generating newborn granule cells in the adult 
mammalian hippocampus.  However, since these studies were performed at the population 
level, rather than at a single-cell or clonal level, the relationship between type 1 and type 2 
hippocampal NPCs remains to be clarified.     
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Newly generated neurons in the SGZ are noted to be involved in learning and 
memory processing, as the hippocampus plays a role in certain forms of learning and 
memory
46
.  In the past several years, various approaches have been taken to understand the 
function of newly generated hippocampal neurons in the adult brain.  After van Praag et al. 
(1999) demonstrated that physical activity (voluntary running) increased hippocampal 
neurogenesis in the adult mouse brain
47
, Farmer et al. (2004) and Kempermann et al. (2002) 
suggested that the exercise-induced increase in the adult hippocampal region is associated 
with enhanced spatial learning in the Morris water maze task
48,49
.  Moreover, some 
researchers attempted to block hippocampal neurogenesis by ablating actively dividing cells 
in the dentate gyrus using pharmacological agents (such as methylazoxymethanol acetate
50
) , 
irradiation
51,52
, or genetic strategies
31,52
.  Observations from these studies indicate that a 
blockage of adult hippocampal neurogenesis affects some, but not all, of hippocampus-
dependent tasks, such as spatial navigation in a Morris water maze and fear-conditioned eye-
blink.  Therefore, newly generated neurons in the hippocampus can be functionally integrated 
into the existing hippocampal circuitry and appear to make a distinct contribution to certain 
types of hippocampal functions.  We do not yet fully understand the significance of 
hippocampal neurogenesis in the adult brain: whether it is for the expansion of memory-
storage capacity to avoid catastrophic interference
53
, for the temporary storage of 
hippocampus-dependent memories before those memories are stored in other parts of the 
brain
54
, for the clearance of older memories by replacing old granule neurons with newborn 
cells
55
, or for the refinement of the existing hippocampal neural circuits
31
.   
 
Neurogenesis-regulating factors 
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 Cellular maintenance and plasticity of NPCs in the neurogenic regions are believed to 
be determined by endogenous (intrinsic) regulators and/or exogenous (extrinsic or 
environmental) signals.  SRY-related HMG box containing gene 2 (Sox2) and basic helix-
loop-helix (bHLH) transcription factors are examples of endogenous regulators.  By 
epigenetic modifications, gene expression in NPCs can be controlled, which alters NPC fates 
as well as synaptic formation during the whole process of neurogenesis.  On the other hand, 
extrinsic signals include a variety of factors from the local microenvironment of NPCs which 
is referred to as the ‘niche’ in vivo.  The niche builds up a neurogenic environment which can 
influence NPC maintenance, differentiation, maturation and functional integration of the 
progeny.  Neighboring cells, such as neurons, glia, and vascular endothelial cells, and their 
secreting or contact-mediated factors as well as physiological or pathological stimuli are 
considered critical signals regulating different stages of adult neurogenesis.        
 
Endogenous factors 
 Sox2 is a transcription factor necessary for maintenance and proliferation of 
NPCs
42,56
.  Graham et al. (2003) reported that constitutive expression of Sox2 prevented 
neuronal differentiation of mouse embryonic NPCs and resulted in the retention of progenitor 
characteristics
56
.  In addition, inhibition of Sox2 signaling caused NPCs to delaminate from 
the SVZ and to exit the cell cycle
56
.  Furthermore, Ferri et al. (2004) examined adult 
neurogenesis in mutant mice in which the Sox2 expression level is about 30% of that of wild-
type mice
57
.  They showed that NPC proliferation was remarkably reduced in both the SVZ 
and SGZ
57
.  Recently, Cavallaro et al. (2008) demonstrated that NPCs isolated from Sox2 
knockdown mutant mice failed to differentiate into mature neurons
58
.  However, an induction 
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of Sox2 overexpression at an early, but not later, stage of differentiation rescued the 
abnormal neuronal phenotype and morphology, and suppressed differentiation of the NPCs 
into glia
58
.  These results suggest that Sox2 plays important roles in the maintenance and 
proliferation of NPCs and also in the early stage of neuronal differentiation of NPCs.  
 bHLH transcription factors, called proneural proteins, are known to control the fate 
commitment of NPCs.  In the SVZ, Ascl1 (also called Mash1) is expressed in type C cells 
during the differentiation into GABAergic neurons in the olfactory bulb
59
.  Berninger et al. 
(2007) and Brill et al. (2009) reported that forced expression of Neurogenin2 (Ngn2) and the 
T-box transcription factor (Tbr1) in the SVZ-derived NPCs induced the NPCs to acquire 
glutamatergic neuronal identity
60,61
.  In the SGZ, the bHLH transcription factors Ngn2 and 
NeuroD are transiently expressed in doublecortin-positive or PSA-NCAM-positive immature 
neurons
62,63
.  Ascl1 is also found in NPCs destined to become granular cells in the dentate 
gyrus
59
.  Recently, Jessberger et al. (2008) demonstrated that retrovirus-mediated 
overexpression of Ascl1 in the SGZ-derived NPCs led them to differentiate into NG2-
positive and MBP-positive oligodendrocyte precursors, rather than into neurons
64
.  These 
results suggest that the expression of proneural proteins influence the fate determination of 
the adult NPCs.   
 Epigenetic modifications can also regulate the expression of genes that are associated 
with various steps of adult neurogenesis
65
.  Mice lacking methyl-CpG-binding protein 1 or 2, 
members of the methylated DNA-binding protein family, showed reduced production of 
immature hippocampal neurons, delayed dendritic development, and altered expression of 
synaptic proteins
66-69
.  Recently, Ma et al. (2009) demonstrated that Gadd45b (a stress 
response gene) is essential for DNA demethylation to express genes, such as BDNF and FGF, 
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that are critical for neural activity-induced neuronal differentiation of the adult 
hippocampus
70,71
.  Furthermore, inhibition of histone deacetylase induced neuronal 
differentiation and suppressed glial differentiation of adult hippocampal NPCs
72
.  These 
results suggest that epigenetic modification is one of the intrinsic mechanisms controlling 
adult neurogenesis.   
 
Environmental control 
In addition to the endogenous factors, adult neurogenesis can be regulated by 
exogenous signals originating from the local microenvironment near multipotent NPCs 
which has a profound influence on the fate of the NPCs
73-78
.  Herrera et al. (1999) reported 
that adult mouse SVZ-derived NPCs were capable of differentiating into olfactory bulb 
interneurons when transplanted into the adult olfactory bulb, although the most of NPCs 
implanted into the neocortex  differentiated into astrocytes
79
.  Suhonen et al. (1996) 
demonstrated that adult rat SGZ-derived NPCs were able to accommodate environmental 
information
80
.  As they transplanted the SGZ NPCs into neurogenic regions (hippocampus or 
rostral migratory stream) or into a non-neurogenic region (cerebellum), NPCs grafted into 
neurogenic (but not non-neurogenic) regions differentiated into neurons
80
.  Interestingly, the 
NPCs grafted in the RMS (then migrated into the olfactory bulb) differentiated into tyrosine 
hydroxylase-positive neurons, i.e. non-hippocampal neurons, while the NPCs implanted into 
the hippocampus became hippocampal neurons
80
.  These results suggest that local 
microenvironments of NPCs retain the ability to control the fate of the NPCs and that adult 
NPCs respond to environmental signals, and their vital properties can be altered by extrinsic 
cues.   
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The neurogenic niche contains several types of cells, diffusible factors, extracellular 
matrix (ECM) components, and topographical cues.  A variety of extracellular signals 
provided from the niches can regulate cell survival, maintenance, differentiation and 
integration of NPCs during early neural development and adult neurogenesis
81,82
.  
Endothelial cells, ependymal cells, astrocytes and mature neurons are the major cellular 
components of neurogenic niches.  In the adult neurogenic regions, dividing NPCs are 
present in proximity to the capillaries
83,84
.  Shen et al. (2004) showed that the endothelial 
cells interacting with NPCs stimulated propagation of NPCs and enhanced neuron 
production
85
.  An angiogenic protein, VEGF, is a factor which can stimulate NPC 
proliferation in the neurogenic regions of the adult rat brain
86
.  It was also observed that the 
expression level of VEGF was increased in the hippocampus where neurogenesis was 
increased by an enriched environmental induction
87
.  In addition, blocking VEGF signaling 
affected enrichment-induced and exercise-induced hippocampal neurogenesis
87,88
.  These 
findings suggest that VEGF is a regulator that can create a proliferative environment in the 
neurogenic regions for self renewal of NPCs.      
Astrocytes are prevailing glial cells in the central nervous system.  Astrocytes 
interacting with NPCs in neurogenic regions are capable of promoting neuronal 
differentiation of the NPCs
89-91
.  Lim and Alvarez-Buylla (1999) reported that SVZ 
astrocytes co-cultured with type C and A cells in contact promoted (a) proliferation of type C 
cells and (b) production and migration of type A cells
89
.  Moreover, Song et al. (2002) 
demonstrated that adult NPCs preferred to adopt a neuronal fate when they were cultured 
onto a hippocampal astrocyte feeder layer
90
 and that the NPC-derived neurons in the 
presence of the astrocytes originating from the neonatal or adult hippocampus displayed 
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functional neuronal characteristics, including the electrophysiological membrane properties 
and synaptic formation typical of newborn cells
91
.  These results suggest that the astrocytes 
in neurogenic regions retain the potential to generate an instructive environment for neuronal 
differentiation of adult NPCs.   
Wnt3 is one of the soluble factors that are produced from the neurogenic astrocytes 
and enhances neuronal differentiation of NPCs
92
.  Lie et al. (2005) demonstrated that 
hippocampal astrocytes expressed Wnt3 and adult hippocampal NPCs expressed receptors 
for Wnt protein and intracellular signaling molecules for Wnt/β-catenin pathway92.  They 
also observed that overexpression of Wnt increased NPC proliferation and that interference 
of Wnt signaling resulted in a lack of doublecortin-positive or MAP2ab-positive neurons in 
the dentate gyrus
92
.  These observations suggest that neurogenic astrocyte-derived factors are 
actively involved in generating new neurons from NPCs in the niches.  In addition to Wnt3, 
numerous factors are proposed to contribute to the neurogenic niches
73,93
.  Morphogenic 
factors (such as BMPs
94,95
, Shh
45
), growth factors (such as EGF, bFGF
14,16,96,97
), 
neurotrophins
98,99
, neurotransmitters
100-103
, neural excitation
104
, and glial cell-derived 
cytokines
105,106
 were demonstrated to induce neuronal differentiation of NPCs.  Moreover, 
matrix metalloprotease-9, retinoic acid, neurogenesin-1, interleukin-1β and interleukin-6 
(further discussed below) were recently reported as factors derived from neurogenic 
astrocytes that can induce neuronal differentiation of NPCs or oligodendrocyte fate-restricted 
progenitor cells
107-109
.  These findings strongly suggest that a neurogenic local 
microenvironment provides molecular controls to regulate neuronal differentiation of NPCs. 
The ECM components contain a complex set of molecules, such as collagens, 
fibronectins, laminins, tanascins, and proteoglycans
110,111
.  These ECM molecules interact 
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with integrin receptors (heteromeric complexes of 18 α and 8 β subunits) on the cell surface, 
and thereby the ECM function as a scaffold for cell adhesion
110,112
.  In addition, the 
interaction between the ECM and integrin triggers intracellular signaling pathways which 
control cell survival, migration, differentiation, neurite outgrowth, and synaptic formation of 
neural precursors and developing neurons
110,112,113
.  Several studies have showed that the 
ECM molecules interacting with integrin receptors influenced differentiation of embryonic 
stem cells
114-116
 or adult hippocampal NPCs
117,118
.   
Matrix metalloproteases (MMPs) are able to degrade all the components of the ECM 
and involved in cell migration by matrix remodeling which can regulate cell-cell and cell-
ECM interaction
119
.  MMPs were reported to regulate differentiation of adult mesenchymal 
stem cells into various lineages
120
.  Recently, Barkho et al. (2008) demonstrated that MMP-3 
and MMP-9 produced from adult SVZ-derived NPCs promoted differentiation of the NPCs 
into migratory progeny
107
.  These results suggest that the ECM molecules are an important 
element in the neurogenic niche not only for cellular support but also for relaying signals 
from extracellular to intracellular environment.          
In concert with other niche signals, topographical cues can also influence stem cell 
adhesion, survival as well as their fates and migration
121
.  Several studies using various kinds 
of stem or progenitor cells, such as umbilical cord-derived hematopoietic stem cells
122
, bone 
marrow-derived osteoprogenitors
123
, mesenchymal stem cells
124
, showed that the distinct 
topographical features (created by various methods for surface functionalization/fabrication) 
had effects on the fates and behaviors of stem or progenitor cells.  Especially, a study by 
Recknor et al. (2006) using adult hippocampal NPCs demonstrated that (a) the grooved 
surface on which the NPCs were cultured increased an alignment in a direction of the groove 
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and (b) in co-cultures with astrocytes, neuronal differentiation of hippocampal NPCs was 
dramatically enhanced on the grooved surface, compared to the non-grooved suface
125
.  In 
addition, Christopherson et al. (2009) reported that hippocampal NPCs cultured on the 
surface of electrospun nanofibers preferred to differentiate into a neuronal lineage, rather 
than a glial lineage
126
.  These findings suggest that topographical cues play a role in 
regulating NPC growth and differentiation and may be developed as an instructive tool to 
control fate specification or directional growth of NPCs.         
 
Interleukin-6 
The cytokine IL-6 is best known as a regulator of hematopoiesis and supports the 
proliferation and survival of bone marrow progenitor cells
127
.  In addition, IL-6 is found in 
the nervous system and in conjunction with its receptor complex can trigger cellular 
responses mediating inflammation, neurogenesis, gliogenesis, cell growth and 
survival, and myelination/demyelination128-131.  In the brain, IL-6 is normally 
expressed at relatively low levels128.  However, during progression of inflammation or 
brain injury, IL-6 protein levels are elevated in the cerebral spinal fluid and brain 
homogenates129,131.  Moreover, chronic over-expression of IL-6 in transgenic mice caused 
neuroanatomical and neurophysiological alterations reminiscent of various neurological 
diseases
129,132,133
.  Interestingly, neurotrophins such as NGF are co-expressed with IL-6 at 
sites of nerve injury
134
.  IL-6 in combination with its specific receptor, IL-6R, has been 
reported to regulate a local supply of neurotrophins that are critical for neuronal survival and 
protection
128,134,135
.  These reports suggest that IL-6 expression is up-regulated under diverse 
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pathological and physiological conditions in the CNS, and also contributes to the production 
and function of neurotrophins at the injured site of the CNS.       
IL-6 is recognized by the high-affinity IL-6R which is expressed on target cells
130,136-
138
.  There are two forms of the IL-6R, one transmembrane form and one soluble form.  The 
latter is believed to be more important for neural signaling
139
.  The IL-6/IL-6R complex 
interacts with gp130, which is a general receptor for the IL-6-type cytokines including IL-11, 
leukemia inhibitory factor, oncostatin M, ciliary neurotrophic factor, and cardiotrophin-
1
137,140,141
.  Gp130, a 130-kD non-ligand-binding membrane glycoprotein, does not bind 
directly to IL-6
141-143
.  The association of IL-6/IL-6R complex with gp130 causes auto-
phosphorylation of the gp130 dimer followed by activation of the JAKs
137
.  The activation of 
JAK/STAT, Ras/ERK or other signal transduction pathways results in the modulation of 
various genes that control neural development
129,135,144-146
.   
Through the JAK/STAT pathway, IL-6 has been implicated in induction of glial 
differentiation from NPCs in the mammalian brain
145,147,148
.  Recent studies examining 
inflammatory responses mediated in part by cytokines, including IL-6, on hippocampal 
neurogenesis showed that IL-6 production from activated microglia interferes with the 
generation of new neurons in the hippocampus of the adult brain
149-151
.  Thus far, the role of 
IL-6 in the neurogenic niche has been suggested to be inhibition of neurogenesis via a 
decrease in NPC proliferation or an increase in glial differentiation, both depleting the pool 
of NPCs.  However, a number of studies have shown that IL-6, in conjunction with its 
specific receptor, can also exert neurotrophic effects
128,152-154
.  By stimulating region-specific 
astrocytes to provide local supplements of neurotrophins, IL-6 facilitates neuronal survival
152
.  
In addition, IL-6 with IL-6R (especially the soluble form) induces neuronal-like 
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differentiation of PC12 cells
144
 and contributes to the regeneration of axotomized mature 
sensory or hippocampal neurons
155-157
.  Therefore the effects of IL-6 on NPC differentiation 
or survival appear to be context dependent. 
Astrocytes are an important source of IL-6 in the CNS
129
 and the expression levels 
vary for different brain regions.  Barkho et al. (2006) demonstrated different gene expression 
profiles of astrocytes originating from neurogenic regions (newborn hippocampus, adult 
hippocampus, and newborn spinal cord) known to promote neuronal differentiation of adult 
hippocampal neural progenitors with cells from non-neurogenic regions (adult spinal cord 
astrocytes and adult skin fibroblasts)
90,105
.  They found that IL-6 mRNA is expressed at a 
relatively higher level in newborn hippocampal astrocytes than in non-neurogenic astrocytes.  
When adult hippocampus-derived neural progenitor cells were cultured in the presence of  
IL-6, neuronal promoter activity and neuronal marker-immunoreactivity were increased
90,105
.   
 
Extracellular calcium influx  
In resting cells, generally, intracellular calcium (Ca) concentration, [Ca]i, is 
maintained at very low level (~100 nM) by Ca pumps present in the plasma membrane (such 
as plasma membrane Ca-ATPases or Na/Ca exchangers) as well as intracellular Ca stores 
(Sarcoendoplasmic reticulum Ca-ATPases)
158
.  [Ca]i can be increased by extracellular Ca 
entry or Ca release from internal Ca stores.  There are several types of channels through 
which extracellular Ca ions enter across plasma membrane; for example, Cav channels, 
ligand-gated channels (such as NMDA receptors), store-operated Ca channels (such as Orai1), 
and transient receptor protein channels.  From internal Ca stores, Ca ions can be released 
through inositol-1,4,5,-triphosphate receptors or ryanodine receptors.       
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In NPCs of young or adult rodent brains, an elevation of [Ca]i is an important event 
for membrane depolarization-dependent neuronal differentiation
103,159-162
.  The elevation of 
[Ca]i in NPCs is known to promote neuronal differentiation and neurite development
103,159-161
.  
Deisseroth et al. (2004) reported that membrane depolarization enhanced adult 
neurogenesis
160
.  They cultured rat hippocampal NPCs onto primary hippocampal neurons 
and glia or fixed hippocampal cellular substrate under differentiation conditions (excluding 
mitogens and including 2% FBS, 0.5 µM all-trans retinoic acid, 10 µM forskolin and 20 
ng/ml NT3) for 2 weeks.  When they applied excitatory stimuli (application of 20 mM KCl 
or 50 µM glutamate) to the NPC cultures, they observed an increase in the fraction of NPC 
progeny that expressed a neuronal marker, MAP2ab.  In addition, the excitatory stimuli were 
sensed by L-type Cav channels (especially Cav1.2 and Cav1.3) and NMDA receptors for 
neuronal differentiation of the NPCs.  Furthermore, they observed that membrane 
depolarization caused changes in gene expression in 6 hours; glial fate gene (Hes1 and Id2) 
expression was down-regulated, and neuronal gene (NeuroD) expression was up-regulated.  
Similarly, D’Ascenzo et al. (2006) reported that membrane depolarization promotes neuronal 
differentiation of cortical NPCs
159
.  They cultured neonatal mouse cortex-derived NPCs in 
the presence of 1% FBS up to 12 days, and applied 50 mM KCl to elicit membrane 
depolarization.  At 0, 3, 6, 9 and 12 days after induction of differentiation, they examined 
phenotypic marker expression, changes in [Ca]i and Ba current density.  They observed that, 
over the culture period, membrane depolarization increased the proportion of cells which 
expressed neuronal markers, increased the amplitude of Ca signal, increased the density of 
high voltage-activated Ba currents which were blocked by nifedipine (5 µM) and increased 
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Cav1.2 expression.  These findings suggest that Ca influx through L-type Cav channels is 
important for induction of neuronal differentiation of NPCs.   
 
Following chronic exposure to IL-6, [Ca]i in developing cerebellar granule cells 
(isolated from ~1 week-old rats) is increased due to excessive activation of NMDA receptors, 
and ends up increasing susceptibility to excitotoxic insults leading to neuronal loss
163-166
.  
Other groups claim that treatment of neonatal rat cerebellar granule neurons with exogenous 
IL-6 prevents neuronal cell death by reducing apoptosis and keeps intracellular Ca from 
being overloaded
167,168
.  In addition, some groups showed a neuroprotective effect of IL-6 on 
hippocampal neurons
126,169-171
.  Considering the variable results obtained from multiple 
studies
165,172,173
, the effects of IL-6 are likely to depend upon neuronal cell type examined, 
the varying times/duration of IL-6 treatment, and concentrations of IL-6 applied.   
We have examined the effects of various concentrations of exogenous IL-6 (0.00001, 
0.0001, 0.001, 0.01, 0.1, 1, 10 and 100 ng/ml) on adult NPC differentiation in vitro
106
.  Adult 
NPC cultures treated with IL-6 greater than 1 ng/ml for 6 days had significantly higher 
fractions of cells expressing a neuronal marker, TuJ1, and possessed significantly longer 
neurite lengths, compared to the cells cultured with no IL-6
106
.  In addition, from all culture 
conditions of different IL-6 concentrations, we observed no considerable changes in the total 
number of cells.  These observations from our previous study suggest that IL-6 treatment 
provides neurogenic effects on NPC differentiation (IL-6 enhanced neuronal differentiation 
of adult NPCs), rather than cytotoxic effects.   
 Qiu et al. (1995) reported that IL-6 treatment caused cerebellar granule neurons to be 
more sensitive to NMDA application and increased [Ca]i when NMDA receptors were 
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agonized
164
.  Moreover, NMDA-induced [Ca]i increase in IL-6-treated cells was significantly 
decreased when [Ca]ext was reduced and intracellular Ca stores were depleted
164
.  They 
further demonstrated that both calcium release from intracellular stores
163
 and Ca influx 
through L-, N- and P/Q-type Cav channels
166
 may contribute to [Ca]i rise in IL-6-treated 
neurons.  These results suggest that IL-6 renders the developing neurons more sensitive to 
membrane depolarization stimuli by increasing [Ca]i.   
In our culture system, we examined the effects of L-type Cav channel antagonists on 
NPC neuronal differentiation in the presence of exogenous IL-6 (see Chapter 4).  
Interestingly, when adult hippocampal NPCs were cultured with L-type Cav channel 
antagonists, IL-6 treatment failed to enhance neuronal differentiation of NPCs.  Thus it is 
presumed that, in our culture system, L-type Cav channels play a critical role in IL-6-
mediated neuronal differentiation of adult NPCs.      
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Abstract 
Rat adult hippocampal progenitor cells (AHPCs) are self-renewing, multipotent 
neural progenitors that have the ability to differentiate into neurons and glia.  Previously, we 
demonstrated that co-culture of AHPCs with postnatal day two, type 1 cortical astrocytes on 
laminin-coated micropatterned polymer substrates facilitates selective neuronal 
differentiation of the AHPCs.  Under this condition, multi-dimensional cell-cell and/or cell-
extracellular matrix interactions, as well as possible soluble factors released from astrocytes 
provided spatial and temporal control selectively enhancing neuronal differentiation and 
neurite alignment on topographically different regions of the same substrate.  To investigate 
the potential role of astrocyte-derived soluble factors as cues involved in neuronal 
differentiation, a non-contact co-culture system was used.  Under control conditions, 
approximately 14% of the AHPCs were immunoreactive (IR) for the neuronal marker, class 
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III β-tubulin (TUJ1-IR).  When co-cultured in physical contact with astrocytes, neuronal 
differentiation increased significantly to about 25%, consistent with our previous results.  
Moreover, under non-contact co-culture conditions using Transwell insert cultures, neuronal 
differentiation was dramatically increased to approximately 64%.  Furthermore, neurite 
outgrowth from neuronal cell bodies was considerably greater on the patterned substrate, 
compared to the non-patterned planar substrate under non-contact co-culture conditions.  
Taken together, our results demonstrate that astrocyte-derived soluble factors provide cues 
for specific neuronal differentiation of AHPCs cultured on micropatterned substrates.  In 
addition, a suppressive influence on neuronal differentiation appears to be mediated by 
contact with co-cultured astrocytes.  These results provide important insights into 
mechanisms for controlling neural progenitor/stem cell differentiation and facilitate 
development of strategies for CNS repair. 
 
 
Introduction  
During development of the central nervous system (CNS), reciprocal interactions 
between neural stem cells and their milieu are important for regulating and coordinating a 
variety of inter- and intra-cellular processes, such as proliferation, differentiation, migration, 
and cell survival.  These developmental events also impact tissue organization and matrix 
remodeling 
2-5
.  The local microenvironment of multipotent neural stem/progenitor cells 
(NPCs), referred to as the neural stem cell ‘niche’, have a profound influence on the fate of 
the NPCs 
6-10
.  Extracellular matrix (ECM) components have been known to regulate the 
differentiation of NPCs 
9,11-15
.  Moreover, numerous studies have demonstrated that 
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astrocytes surrounding NPCs play a critical role in mediating neurogenesis 
1,16,17
.  In addition, 
astrocyte-derived signals have been reported to regulate the structural formation and 
functional plasticity of synapses in developing and adult CNS 
18-20
.  Our previous results 
suggested that the enriched astrocytes enhance neuronal differentiation of NPCs isolated 
from adult rat hippocampus (adult hippocampal progenitor cells, AHPCs) 
1
.  In addition, the 
synergistic combination of spatial control from three-dimensional (3-D) micropatterned 
polystyrene substrates coated with the ECM molecule, laminin, along with the biological 
influence of the astrocytes aligned in the direction of the patterned substrate provided 
guidance cues for promoting neuronal differentiation of the AHPCs 
1
.  Based on these results 
we proposed that, in the multi-dimensional environment, the astrocytes present discrete cues 
to the overlying AHPCs involving contact-mediated or release of soluble factors, or a 
combination of both.  These factors may include specific molecules known to mediate 
cellular mechanisms that regulate cell growth, development, maturation and communication 
among the cells 
21-24
.  The soluble factors released by astrocytes may be spatially restricted 
due to the topography of the micropatterned polystyrene substrate as well as the physically 
aligned astrocytes within the microgrooves.  The astrocyte-derived factors may be locally 
constrained in the microgrooves and could potentially influence AHPC differentiation.  It is 
possible that the stem cell niche has been mimicked in vitro through the presentation of an 
optimal combination of signals necessary for neuronal differentiation of the AHPCs.  
 In the present study, we have investigated the factors responsible for selective 
neuronal differentiation of AHPCs within the micropatterned multi-dimensional environment.  
Non-contact co-cultures were established using Transwell

 semi-porous membrane inserts to 
separate the astrocytes from AHPCs cultured on micropatterned substrates but in the same 
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well.  In this culture system, the membrane inserts prohibit the physical interaction between 
the two types of cells but permit exchange of soluble factors between the cells.  In an effort 
to identify the optimal combination of signals creating biological and spatial control over 
AHPC differentiation, we examined whether the factors responsible for the selective 
differentiation in the co-cultures were contact-mediated or soluble (or both) and possible 
roles of the factors.   
 
 
Materials and Methods 
Micropatterned substrate fabrication 
Micropatterned polystyrene (PS) substrates were prepared as described in the 
previous study 
1,25
.  The pattern dimensions used were 16/13/4 µm [groove width/groove 
spacing (or mesa width)/groove depth] and substrate thickness was approximately 50-70 µm.  
The micropatterned/non-patterned PS substrates were washed in deionized water, sterilized 
with 70% ethanol and used to construct cell growth chambers as described previously 
25
.  The 
PS substrates were coated with poly-L-lysine (PLL, 100 µg/ml; Sigma, St. Louis, MO) 
solution and mouse-derived laminin (LAM, 10 µg/ml; R&D systems, Inc., Minneapolis, MN) 
diluted in Earle’s Balanced Salt Solution (EBSS; Gibco, Grand Island, NY) before plating 
cells.  
 
Astroglial cell isolation and purification 
All animal procedures were conducted in accordance with and had the approval of the 
Iowa State University Committee on Animal Care.  Astrocytes were obtained from cerebral 
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cortex of two day old Sprague-Dawley rats as previously described 
25
.  Dissected and 
dissociated cells were grown in modified minimal essential culture medium (MMEM; Gibco) 
containing minimum essential medium (MEM; Gibco) supplemented with 40 mM glucose, 2 
mM L-glutamine, 1 mM sodium pyruvate and 14 mM sodium bicarbonate, penicillin (100 
IU/ml) and streptomycin (100 µg/ml) with 10% v/v fetal bovine serum (FBS; HyClone, 
Logan, UT), pH 7.35.  The cells were cultured in an incubator (37C, 5% CO2 / 95% 
humidified air atmosphere) until being confluent in 25 cm
2
 tissue culture flasks (T-25; 
Falcon), and screened with an anti-GFAP antibody (see Immunocytochemistry and 
Antibodies below) before use to ensure purification of an enriched population of type-1 
astrocytes.  Greater than 95% of the cells in these astrocyte cultures were immunoreactive for 
the GFAP antibody and no immunostaining for oligodendrocyte (RIP immunoreactivity) or 
neuronal (TUJ1 immunoreactivity) cell-types were observed.  The cultures were not passaged 
more than 5 times.  
 
Adult hippocampal progenitor cell culture 
Adult hippocampal progenitor cells (AHPCs; a gift from Dr. F. H. Gage, La Jolla, 
CA) were originally isolated from the brains of adult Fischer 344 rats and the expanded 
cultures from single clones were infected with retrovirus to express enhanced green 
fluorescent protein (GFP) as reported by Palmer and colleagues 
26
.  The AHPCs were 
cultured as described previously 
1,25
.  Briefly, AHPCs were maintained in 75 cm
2
 tissue 
culture flasks (T-75; Fisher Scientific, Pittsburgh, PA) coated with 10 µg/ml of poly-L-
ornithine (Sigma) and 5 µg/ml of LAM.  The AHPCs were propagated in complete medium 
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containing Dulbecco’s modified Eagle’s medium/Ham’s F-12 (DMEM/F-12, 1:1; Omega 
Scientific, Tarzana, CA) supplemented with N2 (Gibco BRL, Gaithersburg, MD), 20 ng/ml 
basic fibroblast growth factor (human recombinant bFGF; Promega Corporation, Madison, 
WI), and 2.5 mM L-glutamine (Gibco BRL, Gaithersburg, MD).  For in vitro analysis, the 
AHPCs were detached using 0.05% Trypsin-EDTA (Gibco BRL, Gaithersburg, MD), 
harvested , and plated onto the micropatterned/non-micropatterned PS substrates coated with 
PLL (100 µg/ml) and LAM (10 µg/ml in EBSS) (PS-LAM substrates) and maintained in 
appropriate culture media. 
 
Co-culture of astrocytes and AHPCs 
Astrocyte-AHPC co-cultures were established as described previously 
1
.  Briefly, 1.5 
x 10
4
 cells/cm
2
 of AHPCs were plated on top of an astrocyte monolayer and the co-cultures 
were maintained in a mixed medium (referred to as co-culture medium, CCM) that consisted 
of astrocyte MMEM without FBS in a 1:1 mixture with AHPC differentiation medium 
(AHPC complete medium excluding bFGF).  Contact co-cultures, as well as control cultures 
(AHPCs alone and astrocytes alone), were grown for 6 days and then fixed in 4% 
paraformaldehyde in 0.1 M PO4 buffer, pH 7.4 for immunocytochemical analysis.   
To co-culture AHPCs with the astrocytes without physical contact, purified astrocytes 
were seeded onto 0.4 µm semi-porous polyester membrane of Transwell

 inserts inside 6-
well plates (Corning, Inc., Corning, NY) at the same initial plating density, and cultured in 
MMEM including 10% FBS.  After 2 days, the MMEM inside the inserts was replaced with 
CCM following rinses with EBSS and incubated for 4 hours at 37C.  Meanwhile, AHPCs 
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were prepared separately.  1.5 x 10
4
 cells/cm
2
 of AHPCs were plated on PS-LAM substrates 
and allowed to attach for 1 hour before removing the o-ring.  The PS-LAM substrate on 
which AHPCs were plated was placed at the bottom of each well and additional CCM was 
added to the wells.  Astrocytes on the insert membrane were then placed inside the well.  
AHPC-astrocyte non-contact co-cultures were terminated after 6 days and fixed in 4% 
paraformaldehyde for further analysis.   
To obtain astrocyte-conditioned CCM, purified astrocytes were cultured in T-25 
flasks in MMEM including 10% FBS at similar seeding densities to those plated on the insert 
membrane.  After 2 days, the MMEM was replaced by CCM after rinses with EBSS.  After 2 
days of further growth, the CCM conditioned by astrocytes was collected, centrifuged to 
remove any debris and then used to feed AHPC alone cultures without astrocytes.  The 
cultures were fed every 24 hours. 
 
Immunocytochemistry and Antibodies 
 AHPCs cultured on PS-LAM substrates were processed for immunocytochemistry as 
described previously 
25
.  Briefly, fixed cells were incubated in blocking solution containing 
5% normal donkey serum, 0.4% bovine serum albumin (BSA; Sigma), and 0.2% Triton X-
100 (Fisher Scientific), followed by incubation with primary antibodies overnight at 4C.  
After rinsing in phosphate-buffered saline (PBS; 137 mM NaCl, 2.68 mM KCl, 8.1 mM 
Na2HPO4, 1.47 mM KH2PO4, pH 7.4), cells were incubated in the appropriate biotinylated 
secondary antibodies, followed by incubation with streptavidin-conjugated Cy3 (Jackson 
ImmunoResearch, West Grove, PA).  Cell nuclei were stained with 4’, 6-diamidino-2-
phenylindole, dilactate (DAPI), diluted at 1:2000 in PBS.  Preparations were then mounted 
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onto microscope slides using an antifade mounting medium (GelMount; Biomeda Corp., 
Foster City, CA). 
 To identify differentiated neurons, antibodies against class III β-tubulin (TUJ1, mouse 
monoclonal IgG; R&D systems, Inc.) or against microtubule-associated protein 2ab 
(MAP2ab, mouse monoclonal IgG; Sigma) were used at a dilution of 1:750.  To identify 
differentiated glial cells, anti-receptor interacting protein (RIP, mouse monoclonal IgG; 
Developmental Studies Hybridoma Bank) diluted at 1:1,600 for oligodendrocytes 
17,27
 and 
anti-glial fibrillary acidic protein (GFAP, mouse monoclonal IgG; ICN, Costa Mesa, CA) 
diluted at 1:500 for astrocytes were used.  Biotinylated donkey anti-mouse secondary 
antibody (Jackson ImmunoResearch) and Cy3-conjugated streptavidin were diluted at 1:500 
and 1:15,000 in PBS, respectively.  Negative controls were performed in parallel by omission 
of the primary and/or secondary antibodies.  No antibody labeling was observed in these 
controls.  
 
Quantitative analysis of immunocytochemistry 
Following immunocytochemical procedures, the preparations were imaged using a 
Nikon Eclipse (Nikon Corp., Melville, NY) inverted microscope equipped with standard 
epifluorescence illumination and digital camera controlled by MetaMorph software 
(Universal Imaging Corporation, West Chester, PA).  A total of 12 microscopic fields (0.24 
mm
2
/field) from each micropatterned/non-patterned PS-LAM substrate, 6 fields from 
micropatterned half and 6 fields from non-patterned half, were randomly taken.  To calculate 
the percentage of AHPCs immunoreactive (IR) for anti-TUJ1, MAP2ab, RIP or GFAP, the 
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number of GFP-expressing and phenotypic marker-IR AHPCs were divided by the total 
number of cells (DAPI-stained nuclei).   
 
Neurite outgrowth assay 
The images (400 X magnification) of AHPCs co-cultured and immunolabeled against 
TUJ1 were analyzed.  From the images, 21 to 25 TUJ1-IR AHPCs per condition were 
analyzed using MetaMorph software.  The length of major neurites emanating from each cell 
body was measured.  To calculate the average neurite length per cell, total length of the 
major neurites of each cell, measuring from the edge of the cell body to the tip of the growth 
cone, was divided by the number of primary neurites.  Statistical analysis was performed 
using GraphPad PRISM (ver. 3.0).  All tests were two-tailed tests and p-values less than an 
alpha of 0.05 were considered significantly different.  
 
Statistical analyses 
 Statistical analyses were performed on the percentage of the AHPCs IR for each 
antibody of interest.  Since each field was a sub-sample of that half of the substrate, the 
means of the 6 fields were calculated for use in the analysis so that each field would receive 
equal weight.  The experiment followed a split plot design since the treatment (co-culture or 
control) was applied to the entire substrate and both micropatterned and non-patterned halves 
were within one substrate.  Due to this design, there were two random effects in the model, (1) 
for the whole plot effect, consisting of the error term for the treatment and (2) for the split 
plot effect including the pattern effect and the interaction between the treatment and pattern.  
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The whole plot experimental unit was the entire PS-LAM substrate (approximately 1 cm
2
 in 
area) while the split plot experimental unit was the half of the substrate that was either 
patterned or non-patterned.  For each primary antibody (anti-TUJ1, MAP2ab and RIP), N=12 
for the whole plot analysis and N=24 for the split plot analysis.  Mixed model analysis was 
performed on the means using the PROC MIXED procedure in SAS.  All tests performed 
were two-sided tests and p-values less than an alpha value of 0.05 were considered 
significant.  Analysis of the residuals was performed and there was no evidence of 
assumption violations. 
 
 
Results  
 To delineate between contact-mediated and soluble neuronal inducing activities 
associated with the astrocytes, the AHPCs were differentiated in parallel under four different 
culture conditions: (1) AHPCs cultured alone in CCM (AHPCs alone), (2) AHPCs co-
cultured in physical contact with astrocytes (contact co-culture), (3) AHPCs cultured alone 
but in astrocyte-conditioned CCM (conditioned CCM), and (4) AHPCs co-cultured with 
astrocytes in non-contact co-culture conditions (non-contact co-culture).   
 When AHPCs were cultured alone, approximately 14% of the AHPCs were TUJ1-IR, 
13% MAP2ab-IR, 17% RIP-IR and 4% GFAP-IR averaging across the entire substrate (Fig. 
1 A).  In addition, comparison between patterned and non-patterned surfaces of PS-LAM 
substrates revealed no statistically significant differences in phenotypic differentiation of 
AHPCs cultured alone (Fig. 1 B1-B4).  When co-cultured in physical contact with astrocytes, 
approximately 25% of the AHPCs were TUJ1-IR, 21% MAP2ab-IR and 22% RIP-IR (Fig. 1 
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A).  Under these contact co-culture conditions, significantly more AHPCs were 
immunoreactive for the TUJ1 antibody compared to the AHPCs cultured alone (AHPC alone: 
14% versus contact co-culture: 25%; Fig. 1 A).  Furthermore, under the contact co-culture 
conditions, significantly more AHPCs were immunolabeled with the TUJ1 antibodies when 
co-cultured on the patterned side of the substrate compared to the non-patterned side 
(patterned surface: 31% versus non-patterned surface: 19%; α = 0.05; p < 0.0001) (Fig. 1 B1).  
However, no statistically significant differences in AHPC differentiation were observed 
between the patterned and non-patterned sides of the substrates when performing our analysis 
for the other phenotypic markers (MAP2ab, RIP and GFAP shown in Fig. 1 B2, B3 and B4, 
respectively).  These results were consistent with our previous study 
1
.   
 When AHPCs were cultured alone, but in astrocyte-conditioned CCM, we observed a 
significant increase in the percentage of AHPCs immunolabeled with the TUJ1 antibody 
(39% TUJ1-IR) in comparison to AHPCs alone and AHPCs in contact co-culture on the non-
patterned surfaces (α = 0.05; p ≤ 0.0006) (Fig. 1 B1).  These results suggest that the 
astrocytes secrete soluble factors that induce neuronal differentiation of the AHPCs.  
Moreover, this activity appeared to be neurogenic since there was no significant change in 
the percentage of RIP-IR in the AHPCs when compared to the contact co-cultured AHPCs 
(Fig. 1 B3).  To further explore this neurogenic activity, AHPCs were co-cultured with 
astrocytes under non-contact co-culture conditions.  Under these conditions, we observed a 
dramatic increase in the percentage of AHPCs immunolabeled with the TUJ1 antibody (64%), 
illustrating an even greater neuronal induction activity for the soluble astrocyte-derived 
factor (Fig. 1 A).  This level of TUJ1 differentiation was significantly greater compared to 
TUJ1 expression in the other three parallel culture conditions (α = 0.05; p ≤ 0.001).  However, 
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no statistically significant differences in AHPC differentiation were observed between the 
patterned and non-patterned sides of the substrate in astrocyte-conditioned CCM or non-
contact co-cultures for any of the phenotypic markers (TUJ1, MAP2ab, RIP or GFAP; Fig. 1 
B1-B4).  These results provide strong evidence that astrocytes secrete soluble factors that 
facilitate the differentiation of the AHPCs towards a neuronal fate.  This differentiating 
activity of the soluble factor(s) secreted from the astrocytes appears to be specifically 
neurogenic, since no significant effect was observed on the differentiation of RIP- or GFAP-
IR cells.  In addition, the soluble factor(s) might be short-lived, since the proportion of TUJ1-
IR cells cultured in the astrocyte-conditioned CCM (39%) was lower than the proportion of 
TUJ1-IR cells cultured under non-contact co-culture conditions (64%). 
 Morphologically, TUJ1-IR AHPCs were observed to possess longer processes under 
non-contact co-culture condition compared to those in the contact co-cultures.  To investigate 
this possible morphological difference, we performed a quantitative analysis measuring the 
length of primary major neurites emanating from the cell bodies of TUJ1-IR AHPCs.  Under 
both co-culture conditions, the average length of primary processes oriented in the direction 
of the grooves were significantly longer on the micropatterned side compared to that on the 
non-patterned side [Fig. 2; 68.25 µm on patterned surface vs. 40.73 µm on non-patterned 
surface under non-contact co-culture (α = 0.05; p < 0.0001); 52.60 µm on patterned surface 
vs. 39.53 µm on non-patterned surface under contact co-culture (α = 0.05; p = 0.0043)].  
When comparing the morphology of the AHPCs cultured on the patterned sides under both 
co-culture conditions, the average length of neurites of the AHPCs in non-contact co-cultures 
was significantly longer than that in contact co-cultures [Fig. 2; non-contact co-culture vs. 
contact co-culture (α = 0.05; p = 0.006)] or in the AHPCs alone cultures (data not shown).   
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 On the patterned substrates, RIP-IR cells elaborated extensive processes weaving 
intricately inside the grooves and along the mesas of the substrate (Fig. 3 G-I).  On the non-
patterned substrates, extensive radial outgrowth from RIP-IR cells was consistently observed 
(Fig. 4 G-I).  GFAP-IR cells differentiating on the patterned side of the PS-LAM substrate 
often elaborated filamentous processes oriented in the direction of the pattern (Fig. 3 J-L).  
GFAP-IR cells differentiating on the non-patterned side of the substrate usually displayed 
flattened morphologies with large nuclei (Fig. 4 J-L).  
 
 
Discussion 
There are multiple factors in the microenvironment directly surrounding cells that can 
induce and maintain their functional stability.  Elucidating which factors are involved and 
how they interact with cells is extremely helpful in understanding the intra- or inter-cellular 
mechanisms occurring with the in vivo microenvironment.  Micropatterned 3-D constructs 
have been used to study the effects of the microenvironment on cell growth and 
differentiation 
28,29
.  Microfabrication technology has been applied to the design of substrates 
having specific architectures for such purposes 
30
.  Culture environments incorporating these 
substrates are designed to encourage isolated cells to function as they would in their in vivo 
microenvironments or niches.  Our previous study demonstrated an enhancement of selective 
neuronal differentiation of AHPCs co-cultured with astrocytes on PS-LAM substrates 
1
.  
These results provided evidence that physical, chemical and biological cues supplied by the 
surrounding microenvironment could influence the differentiation of the AHPCs by 
providing spatial and temporal control through soluble factors and/or contact-mediated 
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cellular mechanisms which can influence CNS development and function 
12,22
.  In this study, 
we investigated the factors which play an important role in selective neuronal differentiation 
and the directed outgrowth of AHPCs using a non-contact co-culture system on 
micropatterned PS-LAM substrates.    
 
Effect of guidance cues on AHPC differentiation and outgrowth 
In contact co-cultures, we observed a significantly greater percentage of TUJ1-IR 
cells on the patterned side of the substrate compared to the non-patterned side, supporting our 
previous findings that 3-D micropatterned PS substrates can enhance neuronal differentiation 
of AHPCs 
1-3
.  In addition, on the patterned side of the substrate, the neurites of TUJ1-IR 
AHPCs were oriented along the direction of the pattern provided by the 3-D environment and 
they were significantly longer than neurites on the non-patterned side.  Under the non-contact 
co-culture condition, elongation of the neurites oriented in the direction of the grooves were 
also enhanced on the patterned surfaces, although there was no significant difference in TUJ1 
immunoreactivity when cultured on the patterned compared to the non-patterned surfaces.  
These findings demonstrate that the astrocyte-derived factors in combination with 3-D 
micropatterned construct coated with purified ECM (laminin) play a role in promoting 
elongation of the neurites emanating from the differentiated AHPCs.  Interestingly, between 
the two co-culture systems, in the non-contact co-culture, about 2.5 times greater proportion 
of the AHPCs were TUJ1-IR compared to that in contact co-cultures while there were no 
significant differences in the percentage of RIP- or GFAP-IR cells.  This result provides 
strong evidence in support of soluble factor(s) being released from astrocytes co-cultured 
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with AHPCs and that the factor(s) specifically promotes neuronal differentiation.  In addition, 
via a contact-mediated mechanism, astrocyte-associated factors likely provide an activity that 
suppresses neuronal differentiation of AHPCs 
22,32-34
.  To confirm that astrocyte-derived 
soluble factors enhance neuronal differentiation of AHPCs, we cultured the AHPCs alone (in 
the absence of astrocytes) but in astrocyte-conditioned CCM which presumably includes the 
factors released from astrocytes.  When the AHPCs were cultured in the astrocyte-
conditioned CCM, TUJ1 immunoreactivity was increased approximately 3-fold compared to 
when cultured in normal CCM.  Furthermore, there were significantly more TUJ1-IR AHPCs, 
on the non-patterned side of the substrate, in astrocyte-conditioned CCM compared to the 
contact co-culture condition.  These results strongly support our hypothesis that astrocyte-
derived soluble factors selectively stimulate neuronal differentiation of AHPCs which can be 
modulated by a contact-mediated suppressive mechanism.  
During in vitro differentiation, no significant differences in the percentage of 
MAP2ab-IR AHPCs were observed among the different culture conditions.  It is possible that 
astrocyte-derived factors selectively affect axonogenesis and outgrowth of AHPCs, rather 
than dendritic development, since the TUJ1 (class III β-tubulin) antibody is commonly used 
as an axonal marker in young neurons 
35-37
 and the MAP2ab (microtubule-associated protein) 
antibody as a dendritic marker in more mature neurons 
38,39
.  During neuronal development, 
multiple environmental cues can influence the formation and arborization of neuronal 
processes 
40-42
.  Although we observed no significant differences in MAP2ab-IR across the 
different conditions, our results revealed a dramatic increase in TUJ1-IR under co-culture 
conditions and in astrocyte-conditioned CCM in comparison to the AHPC alone cultures.  
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These results suggest that the astrocyte-derived soluble factors may play a critical role in 
neurite extension and axonal development during early neuronal differentiation.     
 
 Microenvironmental regulation of AHPC outgrowth and differentiation 
Our results have demonstrated that the 3-D microenvironment can provide physical 
and/or molecular cues to the micropatterned PS-LAM substrate in the co-culture conditions 
and, thus, influence neuronal differentiation of AHPCs.  However, in the non-contact co-
culture condition, as well as in the astrocyte-conditioned CCM, no significant difference of 
TUJ1 immunoreactivity was observed between the patterned and non-patterned surfaces.  It 
is possible that the AHPCs are in competition with the astrocytes for the released soluble 
factors.  These factors, secreted from astrocytes, in contact co-culture condition, may 
concentrate within the grooves where astrocytes are aligned, but they may presumably be 
taken up by the AHPCs that are proximal to the astrocytes or could influence the astrocytes 
themselves through an autocrine signaling system.  Since many of the factors are short-lived 
43
, it may be unlikely that the factors would have time to accumulate or diffuse across the 
substrate.  However, in the non-contact co-culture, there may be no direct competition among 
AHPCs and astrocytes for the released factors.  Thus it is possible that the AHPCs are 
directly and immediately affected by the soluble cues originating from the astrocytes.  In 
contact co-culture, on the patterned surface, simple diffusion of the soluble factors may be 
less obstructed by the aligned astrocytes than on the non-patterned surface.  Thus, a greater 
proportion of the AHPCs on the patterned surface might be able to differentiate into neuronal 
cells.  However, in the non-contact co-culture condition, diffusion may not be constrained by 
co-cultured astrocytes because the factors secreted from astrocytes would be released directly 
  
60 
into the media and be presented to the AHPCs on both patterned and non-patterned surfaces 
immediately upon release.  The astrocyte-derived factors, thus, are uniformly presented to all 
AHPCs on the substrates, whether or not the surface is micropatterned.  These factors appear 
to be critical cues for maximum effect on neuronal differentiation and outgrowth of AHPCs.  
 Extracellular transport processes play critical roles in cellular morphogenesis.  During 
development, diffusion of morphogens or substances that assign different cell fates or their 
localization at different concentrations specifies many patterns of cell and tissue organization 
44
.  Morphogen transport from a localized site forms microgradients through unknown 
mechanisms which might be simple diffusion or more elaborate mechanisms 
45
.  It is not yet 
known how diffusion may be controlling outgrowth and differentiation in our co-culture 
systems and which factors are released from astrocytes to modulate the neuronal 
differentiation of the neural progenitor cells.  Further studies need to be undertaken to 
distinctly characterize the mechanism(s) behind this enhanced effect and to elucidate the 
specific soluble factor(s) involved.  The controlled in vitro biological model introduced in 
this study can potentially provide new insights into diffusion mechanisms that govern cell 
fates in vivo during development.   
 
 
Conclusion 
 The results of this study have demonstrated that astrocyte-derived soluble factors 
specifically promote neuronal differentiation of adult hippocampal neural progenitor cells 
(AHPCs).  A non-contact co-culture system using semi-porous polyester membrane inserts 
was established to study a potential role of soluble factors derived from neonatal cortical 
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astrocytes in selective neuronal differentiation of AHPCs.  In comparison to control cultures 
(AHPCs cultured alone and AHPCs co-cultured in physical contact with astrocytes), neuronal 
differentiation was dramatically increased when AHPCs were co-cultured with astrocytes 
under non-contact co-culture conditions.  These results suggest that astrocyte-derived soluble 
factors provide cues for enhancing neuronal differentiation of AHPCs cultured on PS-LAM 
substrates.  Furthermore, under non-contact co-culture conditions, neurite length was 
significantly greater when compared with contact co-culture conditions.  In addition, neurite 
outgrowth on the patterned side of the substrates was considerably greater compared to the 
non-patterned, planar surface of the PS-LAM substrates.  Our results demonstrate that 
astrocyte-derived soluble factors facilitate neuronal differentiation of the AHPCs, in 
combination with multiple microenvironmental cues, such as 3-D micropatterned PS 
substrate and purified ECM molecules (laminin).  These results have important implications 
for developing strategies to promote neuronal differentiation from NPCs and for stem cell-
mediated repair of the CNS.  
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Figure legends 
 
Figure 1.  Differentiation of AHPCs under the four different culture conditions - AHPCs 
alone, contact co-culture, conditioned CCM and non-contact co-culture.  (A) Average 
percentages  SEM of phenotypic marker-IR AHPCs, TUJ1 and MAP2ab for neurons and 
RIP and GFAP for oligodendrocytes and astrocytes, respectively.  All phenotypic marker- IR 
cells were averaged over both patterned and non-patterned surfaces.  (B) Quantification of 
phenotypic marker-IR AHPCs on patterned versus non-patterned substrates.  The percentages 
of TUJ1-IR (B1; asterisks, *, statistically significant difference when p ≤ 0.001; NS, no 
statistically significant differences), MAP2ab-IR (B2), RIP-IR (B3) and GFAP-IR (B4) 
AHPCs on patterned and non-patterned substrates in different conditions.  N (number of 
parallel experiments) = 3 or 4.  For the other phenotypic markers (MAP2ab and RIP), under 
all culture conditions, no statistically significant differences in AHPC differentiation were 
observed between the patterned and non-patterned sides of the substrates.  A statistical 
analysis was not performed on GFAP-IR cells as the data were obtained from two 
independent experiments and little differences were observed in the average number of 
GFAP-IR cells for the various experimental conditions.   
 
Figure 2.  Morphological differences between TUJ1-IR AHPCs cultured with astrocytes with 
physical contact or without contact, on non-patterned (NP) or patterned (P) PS-LAM 
substrates.  (A) Representative fluorescence images of TUJ1-IR AHPCs cultured in non-
contact co-culture conditions or contact co-culture conditions on the NP or P side of the PS-
LAM substrates.  These are merged images created by the superimposition of TUJ1-IR (red), 
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GFP-expression (green) and DAPI nuclear counterstain (blue) fluorescent images. Dotted 
white lines indicate the location of a groove on the micropatterned substrate.  Scale bar = 50 
µm.  (B) Line drawing reconstructions of individual TUJ1-IR AHPCs under the different 
culture conditions illustrating the major primary neurites emanating from the cell body.  (B1) 
Reconstructions of TUJ1-IR AHPCs in (A) for each condition.  (B2, B3) Two additional 
examples of line drawing reconstructions of TUJ1-IR cells.  (C) Average primary neurite 
lengths for TUJ1-IR AHPCs growing under the respective culture conditions.  Values are the 
averaged neurite lengths of TUJ1-IR GFP-expressing AHPCs, mean ± SEM.  Asterisks 
indicate statistical difference (p < 0.05, t test).   
 
Figure 3.  Differentiation of AHPCs co-cultured with astrocytes on patterned substrates in 
the non-contact condition.  Fluorescence images of TUJ1-IR (A), MAP2ab-IR (D) RIP-IR (G) 
and GFAP-IR (J) GFP-expressing AHPCs (B, E, H and K, respectively) were merged with 
DAPI nuclei counterstaining (C, F, I and L, respectively).  In non-contact co-cultures, on the 
patterned surfaces, directed neuritic extension from the neuronal cell body was observed with 
prominently longer and elaborated processes in the direction of the grooves than on the non-
patterned surfaces (TUJ1-IR, A-C and MAP2ab, D-F).  RIP-IR cells elaborated extensive 
processes weaving intricately inside the grooves and along the mesas of the substrate (G-I).  
GFAP-IR cells displayed flattened morphologies with large nuclei and in many cases, 
processes strongly immunoreactive for GFAP (J-L).  Dotted white lines indicate the location 
of a groove on the micropatterned substrate.  Scale bar = 20 µm. 
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Figure 4.  Differentiation of AHPCs co-cultured with astrocytes on non-patterned, planar 
substrates in the non-contact condition.  Fluorescence images of TUJ1-IR (A, B), MAP2ab-
IR (D, E), RIP-IR (G, H) and GFAP-IR (J, K) GFP-expressing AHPCs were merged with 
DAPI counterstaining (C, F, I, and L, respectively).  In general, immunoreactive AHPCs 
displayed radially directed processes when cultured on non-patterned, planar substrates.  
Scale bar = 20 µm. 
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Figure 1.  Differentiation of AHPCs under the four different culture conditions - AHPCs 
alone, contact co-culture, conditioned CCM and non-contact co-culture.  
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Figure 2.  Morphological differences between TUJ1-IR AHPCs cultured with astrocytes with 
physical contact or without contact, on non-patterned (NP) or patterned (P) PS-LAM 
substrates.  
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Figure 3.  Differentiation of AHPCs co-cultured with astrocytes on patterned substrates in 
the non-contact condition.   
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Figure 4.  Differentiation of AHPCs co-cultured with astrocytes on non-patterned, planar 
substrates in the non-contact condition.   
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CHAPTER 3. 
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Abstract 
The purpose of this study was to investigate the ability of astrocyte-derived factors to 
influence neural progenitor cell differentiation.  We previously demonstrated that rat adult 
hippocampal progenitor cells (AHPCs) immunoreactive for the neuronal marker, class III β-
tubulin (TUJ1) were significantly increased in the presence of astrocyte-derived soluble 
factors under non-contact co-culture conditions.  Using whole cell patch clamp analysis, we 
observed that the co-cultured AHPCs displayed two prominent voltage-gated conductances - 
tetraethyl ammonium (TEA)-sensitive outward currents and fast transient inward currents.  
The outward and inward current densities of the co-cultured AHPCs were approximately 2.5-
fold and 1.7-fold greater, respectively, than those of cells cultured alone.  These results 
suggest that astrocyte-derived soluble factors induce neuronal commitment of AHPCs.  To 
further investigate the activity of a candidate neurogenic factor on AHPC differentiation, we 
cultured AHPCs in the presence or absence of purified rat recombinant interleukin-6 (IL-6).  
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We also confirmed that the astrocytes used in this study produced IL-6 by ELISA and RT-
qPCR.  When AHPCs were cultured with IL-6 for 6-7 days, the TUJ1-immunoreactive 
AHPCs and the average length of TUJ1-immunoreactive neurites were significantly 
increased, compared to the cells cultured without IL-6.  Moreover, IL-6 increased the inward 
current density to a comparable extent as did co-culture with astrocytes, with no significant 
differences in the outward current density, apparent resting potential, or cell capacitance.  
These results suggest that astrocyte-derived IL-6 may facilitate AHPC neuronal 
differentiation.  Our findings have important implications for understanding injury-induced 
neurogenesis and developing cell-based therapeutic strategies using neural progenitors.  
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Abbreviation 
 
AHPC, adult hippocampal progenitor cell  
bFGF, basic fibroblast growth factor 
Brain-Astro, astrocytes isolated from whole cerebral hemispheres of the brain 
CCM, co-culture medium 
CNS, central nervous system 
CTX-Astro, astrocytes isolated from cortical region of the brain 
DIV, days in vitro 
GFAP, glial fibrillary acidic protein 
HC-Astro, astrocytes isolated from hippocampal region of the brain 
IL-6, interleukin-6 
MEM, minimal essential medium 
MMEM, modified MEM 
NCCC, non-contact co-culture  
NPC, neural progenitor cell 
NGF, nerve growth factor 
NT, neurotrophin 
PSA-NCAM, polysialic acid neural cell adhesion molecule 
RIP, receptor interacting protein 
TEA, tetraethyl ammonium  
TUJ1, class III β-tubulin 
TTX, tetrodotoxin  
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Introduction 
The cytokine interleukin-6 (IL-6) is best known as a regulator of 
hematopoiesis(Eglitis and Mezey 1997).  In addition, IL-6 is found in the nervous system and 
in conjunction with its receptor complex can trigger cellular responses mediating 
inflammation, neurogenesis, gliogenesis, cell growth and survival, and 
myelination/demyelination(Gadient and Otten 1997; Gruol and Nelson 1997; Van Snick 
1990; Van Wagoner and Benveniste 1999).  In the brain, IL-6 is normally expressed at 
relatively low levels(Gadient and Otten 1997).  However, during progression of 
inflammation or brain injury, IL-6 protein levels are elevated in the cerebral spinal fluid and 
brain homogenates(Gruol and Nelson 1997; Van Wagoner and Benveniste 1999).  Chronic 
over-expression of IL-6 in transgenic mice caused neuroanatomical and neurophysiological 
alterations reminiscent of various neurological diseases(Campbell et al. 1993; Gruol and 
Nelson 1997; Vallieres et al. 2002).  Interestingly, neurotrophins (NTs) such as nerve growth 
factor (NGF), are co-expressed with IL-6 at sites of nerve injury(Otten et al. 2000).  IL-6 in 
combination with its specific receptor, IL-6R, has been reported to regulate a local supply of 
NTs that are critical for neuronal survival and protection(Gadient and Otten 1994; Gadient 
and Otten 1997; Otten et al. 2000).  These reports suggest that IL-6 expression is up-
regulated under diverse pathological and physiological conditions in the CNS, and also 
contributes to the production and function of NTs at the injured site of the CNS.       
Astrocytes are an important source of IL-6 in the CNS(Gruol and Nelson 1997) and 
the expression levels vary for different brain regions.  Barkho et al. (2006) demonstrated that 
astrocytes originating from neurogenic regions (newborn hippocampus, adult hippocampus, 
and newborn spinal cord) compared with cells from non-neurogenic regions (adult spinal 
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cord astrocytes and adult skin fibroblasts) displayed different gene expression 
profiles(Barkho et al. 2006; Song et al. 2002).  IL-6 mRNA was expressed at relatively 
higher levels in newborn hippocampal astrocytes than in non-neurogenic astrocytes.  
Furthermore, when adult hippocampus-derived neural progenitor cells were cultured in the 
presence of  IL-6, neuronal promoter activity and neuronal marker-immunoreactivity were 
increased(Barkho et al. 2006).  Our previous results confirmed that neuronal differentiation 
of adult hippocampal progenitor cells (AHPCs) was enhanced by soluble factors derived 
from neonatal astrocytes(Oh et al. 2009; Recknor et al. 2006).  However, it was not known if 
astrocyte-derived IL-6 influenced NPC differentiation into functional neurons.   
In the present study, we tested the hypothesis that IL-6 produced from neurogenic 
astrocytes is a key regulator in our culture system that stimulates functional differentiation of 
AHPCs to a neuronal fate.  Using immunocytochemical analysis and whole-cell recording, in 
the presence of exogenous IL-6, we observed that (1) neuronal marker expression was 
increased, (2) the average length of neurites from neuronal-restricted AHPCs was increased 
and (3) voltage-gated inward current density was increased with no significant differences in 
voltage-gated outward current density, apparent resting membrane potential or cell 
capacitance.  These results demonstrate that astrocyte-derived IL-6 enhances neuronal 
differentiation of AHPCs.   
 
 
Materials and Methods 
Cell culture 
All animal procedures were conducted in accordance with and had the approval of the 
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Iowa State University Committee on Animal Care.  Astrocytes were isolated from cerebral 
cortices and hippocampi of postnatal day two Sprague-Dawley rat brains as described 
previously(Recknor et al. 2004).  Adult hippocampal progenitor cells (AHPCs from F. Gage, 
Salk Institute, La Jolla, CA), isolated from the brains of adult Fischer 344 rats and infected 
with retrovirus to express enhanced green fluorescent protein (GFP)(Gage et al. 1995; Ray et 
al. 1995) were maintained as described previously(Oh et al. 2009) (for details, see 
Supplementary Materials and Methods online).   
 
Astrocyte-AHPC co-culture  
Transwell

 inserts (Corning, Inc., Corning, NY) were used to establish co-cultures of 
astrocytes and AHPCs growing together in the absence of physical contact (referred to as 
non-contact co-culture, NCCC) as described previously(Oh et al. 2009) (for details, see 
Supplementary Materials and Methods online).   
 
IL-6 treatment 
To examine the effect of IL-6 on AHPC differentiation, purified rat recombinant IL-6 
(20 ng/ml; R&D Systems) and/or neutralizing antibody against IL-6 (anti-IL-6) produced in 
goat (10 ng/ml; R&D Systems) were added to the culture media.  A concentration-response 
analysis was performed to determine optimal concentrations of purified IL-6 (Supplementary 
Figure 1).  Based on this analysis and from the literature(Barkho et al. 2006; Hakkoum et al. 
2007), an IL-6 concentration of 20 ng/ml was used in this study.  The anti-IL-6 neutralizing 
antibody was tested at various concentrations (10, 100 and 1000 ng/ml in NCCCs of 
astrocyte-AHPC; 10 and 1000 ng/ml in AHPC alone cultures with 20 ng/ml of purified IL-6).  
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There were no significant effects of these concentrations of blocking antibody on the 
percentages of TUJ1- or RIP-immunoreactive AHPCs (see ‘Immunocytochemistry’ section 
below) when the cells were cultured with the antibody in the absence of IL-6 (data not 
shown).  Thus, the anti-IL-6 neutralizing antibody was used at 10 ng/ml in this study.  As a 
control for the neutralizing antibody, a purified preimmune goat immunoglobulin G (goat 
IgG; Sigma-Aldrich) was used at the same concentration.   
 
Immunocytochemistry 
AHPCs cultured on laminin-coated substrates were processed for 
immunocytochemistry according to standard protocols described previously(Oh et al. 2009).  
Fixed AHPCs were labeled with antibodies against phenotypic markers, class III β-tubulin 
(TUJ1, mouse monoclonal IgG; R&D Systems), receptor interacting protein (RIP in 
concentrated form supplied by vendor, mouse monoclonal IgG; Developmental Studies 
Hybridoma Bank) and glial fibrillary acidic protein (GFAP, mouse monoclonal IgG; Lab 
Vision Corp., Fremont, CA)  Biotinylated donkey anti-mouse secondary antibody and Cy3-
conjuated streptavidin (Jackson ImmunoResearch, West Grove, PA) were used for 
visualizing the primary antibody labeling.  Nuclei were counterstained with 1 µM 4’, 6-
diamidino-2-phenylindole, dilactate (DAPI).  Preparations were then mounted onto 
microscope slides using GelMount antifade mounting medium (Biomeda Corp., Foster City, 
CA) (for details, see Supplementary Materials and Methods online).   
 
Neurite outgrowth assay 
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AHPCs were cultured in the absence or presence of purified IL-6 at different 
concentrations (from 0.00001 to 100 ng/ml; Figure 3 C) for 6 days.  After fixation, cultured 
AHPCs were immunolabeled for TUJ1 and imaged using a 40X objective.  From the images, 
17 to 22 TUJ1-immunoreactive AHPCs per condition were analyzed for the length of 
neurites emanating from the cell body using ImageJ, image processing and analysis program 
(developed at the National Institutes of Health, http://rsbweb.nih.gov/ij/) (for details, see 
Supplementary Materials and Methods online).  
 
Whole cell patch clamping 
AHPCs were plated on a laminin-coated polystyrene substrate that was attached to the 
bottom of a recording chamber made of a 25-mm circular coverglass (Cat # 12-545-102, 
Fisher Scientific) with an attached silicone O-ring (Cat # 9396K22, McMaster Carr Supply, 
Atlanta, GA).  After the cells were cultured in the recording chamber for a designated culture period, the 
chamber with cells was placed on the stage of a Nikon Diaphot inverted microscope (Tokyo, 
Japan).  The cultures were bathed in an external solution containing (in mM): 145 NaCl, 3 
KCl, 10 HEPES, 8 glucose, 2 MgCl2, 3 CaCl2 (pH 7.4, adjusted with NaOH).  Patch pipettes 
were pulled from thick-walled borosilicate glass capillaries (Cat # PG52165-4, World 
Precision Instrument, Inc., Sarasota, FL) and fire-polished to resistances of 3 - 5 MΩ when 
filled with internal solution containing (in mM): 136.5 K-gluconate, 17.5 KCl, 9 NaCl, 10 
HEPES, 8 glucose, 0.2 EGTA and 1 MgCl2 (pH 7.2, adjusted with KOH).  For the cultures 
maintained in the presence of basic fibroblast growth factor (bFGF), cells were randomly 
chosen for recording.  For the cells cultured under differentiation condition, cells that 
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possessed neuronal-like morphology typical of TUJ1-immunoreactive cells were 
selected(Ray et al. 1993; Sah et al. 1997).   
Conventional whole cell recording was performed at room temperature using an 
Axopatch 200B patch clamp amplifier (Molecular Devices, Sunnyvale, CA) and IT-16 
interface (Instrutech, Inc.) or an EPC9 (HEKA Instruments, Inc., Bellmore, NY).  Current 
was filtered at 1 kHz and digitized at 5 kHz.  Stimulation and acquisition were controlled 
with PULSE software (v8.78, HEKA Instruments, Inc.).   
A liquid junction potential of 14.3 mV was estimated using JPCalc software (P. H. 
Barry, University of New South Wales).  Membrane voltages were corrected after the 
experiment by subtraction of the liquid junction potential; the apparent resting potential was 
estimated 10 min after break-in to the whole cell mode as the zero current potential during 
current-clamp recording and corrected for the liquid junction potential.  Ionic currents were 
measured by application of 100 ms depolarizing steps in 10 mV increments from the holding 
potential (VH) of -100 mV.  The interpulse interval was 5 s.  Current densities were 
calculated by normalizing the peak currents to the membrane capacitance (Cm).  Input 
resistance (Rin) was estimated from the reciprocal of the slope of voltage ramps at 
subthreshold potentials in the whole cell mode; because the values of Rin estimated this way 
were similar to seal resistances, we could only place a lower limit on the true Rin.  
Pharmacological blockade of inward and outward currents was performed with 300 
nM tetrodotoxin (TTX; Sigma-Aldrich) for voltage-gated sodium (Na
+
) channels, or 5 mM 
tetraethylammonium (TEA; Sigma-Aldrich) for voltage-gated potassium (K
+
) channels, 
respectively.   
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Statistical analysis 
Statistical analysis was performed using GraphPad PRISM (ver. 3.0).  All tests were 
two-tailed tests and p-values less than an alpha of 0.05 were considered significantly 
different.  
 
 
Results 
Astrocyte-derived soluble factors enhance AHPC neuronal differentiation 
Our previous results demonstrated that astrocyte-derived soluble factors induced 
neuronal differentiation of AHPCs(Oh et al. 2009).  When AHPCs were co-cultured with 
astrocytes (isolated from neonatal rat brain, cerebral hemispheres) in the absence of physical 
contact (referred to as non-contact co-culture, NCCC) using Transwell

 inserts, neuronal 
differentiation of AHPCs was significantly augmented compared to AHPCs cultured alone 
(without astrocytes) (Figure 1; 63.7% in NCCC vs. 13.1% in alone culture).  To further 
delineate the source of neurogenic activity, we isolated separately hippocampal and cortical 
astrocytes.  Immunocytochemical analysis revealed that under NCCC conditions, using either 
hippocampal or cortical astrocytes, the percentage of TUJ1-immunoreactive (IR) AHPCs was 
significantly higher compared to that when AHPCs were cultured alone (Figure 1).  In 
addition, the percentage of TUJ1-IR cells was significantly greater for AHPCs when co-
cultured with hippocampal astrocytes (NCCC with HC-Astro) than with cortical astrocytes 
(NCCC with CTX-Astro) (Figure 1; 54.4% in NCCC with HC-Astro vs. 34.2% in NCCC 
with CTX-Astro).  These results suggest that the astrocyte-derived soluble factors induce 
neuronal differentiation of AHPCs, which is consistent with our previous results(Oh et al. 
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2009).  Moreover, on a cell per cell basis, hippocampal astrocytes appear to possess 
significantly greater neurogenic activity, compared to cortical astrocytes.   
The astrocyte-derived factors appeared specific for inducing AHPC neuronal 
differentiation, because no effect was observed on astroglial differentiation (Figure 1; RIP 
and GFAP immunoreactivities).  Under NCCC using astrocytes from whole cerebral 
hemispheres (referred to as brain astrocytes, Brain-Astro), the percentage of 
oligodendrocytes (RIP-IR AHPCs) was greater than when AHPCs were cultured alone 
(Figure 1; 26.8% in NCCC with Brain-Astro vs. 13.0% in alone culture).  However, under 
NCCC using either cortical astrocytes or hippocampal astrocytes, there was no significant 
difference in RIP immunoreactivity compared to the AHPCs cultured alone (Figure 1; 15.4% 
in NCCC with HC-Astro vs. 19.1% in NCCC with CTX-Astro vs. 13.0% in alone culture).  
This result demonstrates that the factors from cortical astrocytes or from hippocampal 
astrocytes have little effect on oligodendrocytic differentiation of AHPCs.  However, whole 
brain astrocytes have a small incremental effect on oligodendrocytic differentiation of 
AHPCs.  
To examine whether the AHPCs with neuronal morphology possessed membrane 
characteristics consistent with neuronal differentiation, patch clamp analysis in conventional 
whole cell mode was performed.  AHPCs were cultured in the absence or presence of the 
astrocytes for 6-7 days or 9-10 days.  AHPCs from both conditions had similar capacitance 
(Cm) values (Table 1) and input resistance (Rin, > 2 GΩ) (data not shown).  The apparent 
resting potential was more hyperpolarized under differentiation conditions compared to the 
proliferation conditions (Table 1).  AHPCs at 6-7 DIV in co-culture with brain-derived 
astrocytes showed significantly greater current densities for both TEA-sensitive sustained 
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outward currents (voltage-gated K
+
 channel-mediated) and transient inward currents 
(voltage-gated Na
+
 channel-mediated) in response to the voltage-step stimuli compared to the 
AHPCs cultured alone (Figure 2 A2 and B2; Table 1).  These results demonstrate that 
astrocyte-derived neurogenic factors promoted neuronal differentiation with respect to the 
electrical membrane properties of AHPCs, as well as in cell morphology. 
 
IL-6 enhances neuronal differentiation of AHPCs 
IL-6 has been suggested as a candidate astrocyte-derived factor that can induce 
AHPC differentiation(Barkho et al. 2006).  To investigate the molecular mechanism(s) by 
which astrocytes promote neurogenesis, a neutralizing antibody against rat IL-6 (referred to 
as anti-IL-6) was added to the AHPC cultures.  As a control, equal concentrations of affinity-
purified goat IgG were added to parallel cultures.  Addition of anti-IL-6 to the hippocampal 
NCCC resulted in a significant decrease in neuronal differentiation of the AHPCs 
(percentage of TUJ1-IR AHPCs: 54.4% without anti-IL-6 vs. 27.7% with anti-IL-6) (Figure 3 
A).  In contrast, the blocking antibody had no effect on TUJ1 immunoreactivity in cortical 
NCCC (34.2% without anti-IL-6 vs. 35.2% with anti-IL-6) (Figure 3 A).  These results 
suggest that IL-6 derived from neurogenic hippocampal astrocytes may play a critical role in 
neuronal differentiation of AHPCs.   
To examine further whether IL-6 itself can directly influence AHPC differentiation, 
we cultured AHPCs (alone, in the absence of astrocytes) with or without rat recombinant IL-
6 for 6 days.  Incubation with purified IL-6 specifically increased the percentage of TUJ1-IR 
AHPCs (38.5% with IL-6 vs. 13.1% without IL-6) with no effect on the percentages of RIP- 
or GFAP-IR AHPCs (RIP immunoreactivity: 13.6% with IL-6 vs. 13.0% without IL-6; 
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GFAP immunoreactivity: 1.5% with IL-6 vs. 1.6% without IL-6) (Figure 3 B).  Moreover, 
the IL-6-mediated augmentation of TUJ1 immunoreactivity was eliminated by addition of 
anti-IL-6 neutralizing antibody (Figure 3 B).  These results suggest that IL-6 is a key 
molecule that can induce neuronal differentiation of AHPCs.   
In addition, IL-6 influences neurite outgrowth of AHPCs.  When AHPCs were 
cultured in the presence of various concentrations of purified IL-6, the average length of 
TUJ1-IR processes extending from the soma of TUJ1-IR AHPCs was positively correlated 
with the concentration of IL-6 (Figure 3 C).  At concentrations greater than 1 ng/ml of IL-6, 
the average process length per cell was significantly longer than that of the control cultures 
(AHPCs alone with no IL-6).  The average length of neurites analyzed from the cells cultured 
in the presence of IL-6 was approximately 40 µm, which is comparable to the process length 
of AHPCs co-cultured with enriched postnatal astrocytes as demonstrated previously(Oh et al. 
2009).  However there was no significant difference observed in the total length of processes 
per cell with increasing IL-6 concentrations (Supplementary Figure 2).  These data indicate 
that IL-6 increases the length of TUJ1-expressing neurites from AHPCs undergoing neuronal 
differentiation.   
To investigate the influence of IL-6 on electrical membrane properties, AHPCs were 
cultured under differentiation conditions in the absence or presence of IL-6.  The AHPCs 
cultured in the presence of IL-6 showed significantly greater transient inward currents 
compared to cells cultured in the absence of IL-6 (Figure 4; Table 2).  In three out of three 
IL-6-treated AHPCs for which it was tested, 300 nM TTX inhibited the transient inward 
currents, which suggests mediation by TTX-sensitive Na
+
 channels.  Augmentation of the 
transient inward current in the AHPCs cultured in the presence of IL-6 was comparable to 
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that seen with the AHPCs co-cultured with astrocytes.  The effect appears to be selective for 
Na
+
 current, as no enhancement of a presumed K
+
 current (TEA-sensitive current) was 
apparent (Table 2).  The observed changes in Cm and apparent resting potential due to 
exogenous IL-6 were statistically insignificant (Table 2).  These results suggest that IL-6 can 
facilitate expression of voltage-gated Na
+
 channels during AHPC differentiation into neurons. 
 
IL-6 is produced from the co-cultured astrocytes  
To quantify the amount of IL-6 protein secreted into the culture media, we performed 
enzyme-linked immunosorbent assays (ELISA) (Supplementary Figure 3 A).  These results 
demonstrate that (a) the major source of IL-6 production in the non-contact co-culture system 
was the astrocytes, rather than AHPCs, and (b) the IL-6 production capability of astrocytes 
appeared to be independent of the AHPCs co-cultured with them.  The expression levels of 
IL-6, its specific receptor, IL-6R (transmembrane and soluble) and gp130 in AHPCs and 
astrocytes were  analyzed by RT-qPCR (Supplementary Figure 3 B, C) (for details, see 
Supplementary Results and Discussion online).   
 
 
Discussion 
The local microenvironment is crucial in regulating the survival, proliferation and 
differentiation of NPCs(Conover and Notti 2008; Garcion et al. 2004; Soen et al. 2006; Watt 
and Hogan 2000; Wurmser et al. 2004).  In addition to the extracellular matrix (ECM), 
astrocytes surrounding NPCs can provide various biological cues for regulating neurogenesis 
in vivo(Lim and Alvarez-Buylla 1999; Recknor et al. 2006; Song et al. 2002).  Our previous 
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results demonstrated that astrocyte-derived soluble factors promote neuronal differentiation 
of AHPCs, in combination with three-dimensional spatial control(Oh et al. 2009).  In the 
present study, we identified a candidate molecule, IL-6, which specifically induces neuronal 
differentiation of adult NPCs by demonstrating that (1) newborn hippocampal astrocytes 
produced more IL-6 protein than non-neurogenic skin-derived fibroblasts and (2) IL-6 
treatment increased the fraction of TUJ1-immunoreactive cells.  These results support the 
earlier findings by Barkho and colleagues(Barkho et al. 2006).  Furthermore, in our study we 
reported for the first time electrophysiological properties of AHPCs undergoing 
differentiation in the presence of IL-6.  Our findings demonstrate that IL-6 derived from 
neurogenic astrocytes promotes functional differentiation of AHPCs and accelerates neurite 
outgrowth.  
 
Astrocyte-derived IL-6 promoting neuronal differentiation of AHPCs 
Previously we demonstrated that the percentage of TUJ1-IR AHPCs was dramatically 
increased when AHPCs were co-cultured with astrocytes compared to the cells cultured 
alone(Oh et al. 2009).  This result suggested that astrocyte-derived soluble factors enhance 
neuronal differentiation of AHPCs.  To identify the source of neurogenic activity of the 
astrocytes, we separated the hippocampi, a neurogenic region of the brain, from the 
surrounding cerebral cortex, thus generating two distinct populations of astrocytes.  A 
significantly higher percentage of AHPCs differentiated into neurons (TUJ1 
immunoreactivity) when co-cultured with hippocampal astrocytes compared to those co-
cultured with cortical astrocytes.  This suggests that the soluble factors derived from 
hippocampal astrocytes are in part responsible for the increase in neuronal differentiation of 
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AHPCs, which agrees with the previous finding that astrocytes from adult hippocampus can 
instruct the NPCs to adopt a neuronal fate(Song et al. 2002).     
The increased neuronal differentiation of AHPCs co-cultured with hippocampal 
astrocytes was diminished in the presence of neutralizing antibody against IL-6.  However, 
the neutralizing antibody had no effect on the TUJ1 immunoreactivity of AHPCs co-cultured 
with cortical astrocytes.  These results might be explained by the combined action of multiple 
factors produced by astrocytes and/or AHPCs.  For example, hippocampal astrocytes may 
produce additional neurogenic factors that promote neuronal differentiation of AHPCs.  
Recently, metalloprotease-9, all-trans retinoic acid, Wnt3 and neurogenesin-1 were reported 
as factors derived from neurogenic astrocytes that can induce neuronal differentiation of 
NPCs or oligodendrocyte fate-restricted progenitor cells(Barkho et al. 2008; Barkho et al. 
2006; Gaughwin et al. 2006; Kornyei et al. 2007; Lie et al. 2005; Ueki et al. 2003).  
Furthermore, cortical astrocytes appear to express developmental signals, such as Notch, 
Noggin, sonic hedgehog and thrombospondin-1 which can participate in generating a 
neurogenic microenvironment surrounding NPCs(Lu and Kipnis; Taupin 2006).  Factors 
derived from cortical astrocytes may also suppress neuronal differentiation of AHPCs.  For 
instance, insulin-like growth factor (IGF)-1 is known to be important for early neural 
development as well as maintenance of the adult CNS (Russo et al. 2005).  In the adult CNS, 
IGF-1, which is expressed both in neurons and astrocytes, binds to IGF binding proteins 
(IGFBPs) that are mainly produced by astrocytes(Chesik et al. 2007; Feldman et al. 1997; 
Russo et al. 2005; Ye et al. 2004).  IGFBP-6, in particular, was reported to be expressed at 
much higher levels in non-neurogenic astrocytes than in neurogenic-astrocytes, so it is 
thought to inhibit neuronal differentiation of NPCs(Barkho et al. 2006).  Bone morphogenic 
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proteins (BMPs), having multiple roles in embryonic brain development, are also known to 
influence glial and neuronal differentiation of NPCs(Gross et al. 1996; Taga and Fukuda 
2005; Zhang and Li 2005).  Therefore, the neurogenic effect of IL-6 released from cortical 
astrocytes may be prevented by other cortical astrocyte-derived factors.  Taken together, 
reduced neuronal differentiation by neutralizing antibody against IL-6 demonstrates that an 
astrocyte-derived soluble factor, IL-6, is a critical soluble factor that can enhance neuronal 
differentiation of AHPCs.  Furthermore, astrocytes isolated from the hippocampal region, a 
neurogenic niche, may be more potent in inducing neuronal differentiation of AHPCs than 
the general astrocyte population.         
Direct application of IL-6 enhanced AHPC neuronal but not glial differentiation.  
Moreover, IL-6-mediated neuronal differentiation was neutralized by anti-IL-6 function-
blocking antibody.  This result suggests that AHPCs are capable of responding with neuronal 
differentiation to exogenous IL-6.  RIP immunoreactivity of AHPCs under co-culture 
conditions tended to be slightly higher compared to that of AHPCs cultured alone.  This 
result is not surprising because numerous soluble factors derived from the astrocytes may 
influence NPC fate specification during CNS development or inflammation 
response(Martino and Pluchino 2006; Taupin 2008).  For example, sonic hedgehog secreted 
from reactive astrocytes can induce NPCs to differentiate into oligodendrocytes as well as 
neurons(Martino and Pluchino 2006).  Platelet-derived growth factor produced by astrocytes 
has been known to stimulate the proliferation of oligodendrocyte precursors in the CNS(Abe 
2000; Martino and Pluchino 2006).  Interestingly, oligodendrocyte differentiation (assessed 
by RIP immunoreactivity) from AHPCs co-cultured with astrocytes from the whole cerebral 
hemispheres (including the hippocampus) was significantly higher than that under control 
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conditions (AHPCs cultured alone).  However, under co-culture conditions with either 
cortical or hippocampal astrocytes, the RIP immunoreactivity was not significantly different 
compared to that under control conditions.  Region-specific factors may be produced only 
from the cortical or hippocampal astrocytes that potentially promote oligodendrocyte 
differentiation of AHPCs.  The oligodendrocyte differentiation-promoting activity of those 
factors may be reinforced by juxtacrine or paracrine stimulation when the cortical and 
hippocampal astrocytes are in close proximity.    
 
Neurite extension in the presence of IL-6 
 IL-6 application specifically influenced TUJ1 immunoreactivity of AHPCs in a 
concentration-dependent manner, with no effect on RIP immunoreactivity.  Above 1 ng/ml of 
IL-6, the percentage of TUJ1-IR AHPCs appeared to have reached saturation.  In addition, 
the average length of processes extended from the TUJ1-IR AHPCs was significantly longer 
than that for the cells in the control condition (0 ng/ml of IL-6), although neither the average 
number of processes per cell (Supplementary Table 1) nor the total length of processes 
(Supplementary Figure 2) was significantly different.   
Marz et al. (1999) reported that the application of the IL-6/IL-6R fusion protein 
(covalently linked by an intermediate peptide(Fischer et al. 1997)) increased expression 
levels of neurotrophins (NTs) in brain-derived astrocytes(Marz et al. 1999).  Both 
hippocampal and cortical astrocytes express NGF at high levels following IL-6 
treatment(Marz et al. 1999).  NGF can suppress the activation of STAT3 which itself inhibits 
neurite outgrowth of PC12 cells(Ihara et al. 1997).  Moreover, hippocampal and cortical 
astrocytes exclusively express NT-3 and NT-4/5, respectively(Marz et al. 1999).  NT-3 
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facilitates neuronal differentiation and neurite outgrowth of mouse NPCs through the 
MAPK-ERK pathway(Lim et al. 2007).  Thus, the astrocyte-derived IL-6 may stimulate 
neurogenic astrocytes that express IL-6R to produce NTs, such as NGF and NT-3.  Such NTs 
might then inhibit STAT3 activation and induce ERK activation following MAPKK 
activation.  Therefore, the IL-6 released from the astrocytes may be a key molecule that 
influences neuronal differentiation and neurite outgrowth of AHPCs. 
 
Electrophysiological properties of AHPCs   
For whole cell patch clamp analysis, only cells possessing a neuronal morphology 
were selected for recording.  In this analysis, we examined resting potential, capacitance and 
current density.  AHPCs cultured in the absence or presence of IL-6 showed similar apparent 
resting potentials, -79 ~ -82 mV on average.  Schmidt-Hieber et al. (2004) reported that the 
resting membrane potentials for PSA-NCAM-expressing newborn hippocampal granule cells 
were about -75 mV which was similar to that for PSA-NCAM immunonegative mature cells 
(about -81 mV)(Schmidt-Hieber et al. 2004).  Resting potentials of AHPCs cultured under 
differentiation condition for 1 week were comparable to the values for the granule cells in the 
hippocampus.  AHPCs cultured without or with IL-6 also showed similar membrane 
capacitance values in the range of 10 ~ 15 pF.  These values are comparable to those reported 
for rat hippocampus-derived NPCs cultured for less than 2 weeks in vitro with various 
factors(Sah et al. 1997).  Considering that cell capacitance is proportional to cell surface area, 
more mature dentate granule cells extending longer dendrites, as expected, have greater cell 
capacitance than do their immature counterparts(Schmidt-Hieber et al. 2004; van Praag et al. 
2002).  In brain slices, 4 week-old hippocampal neurons displaying complex morphologies 
  
94 
with highly branched dendritic arborizations exhibit 3.5-times higher capacitance values(van 
Praag et al. 2002) than do AHPCs cultured for 6 days.  From our result TUJ1-IR AHPCs 
cultured for 6 days in the presence of exogenous IL-6 displayed a total length of presumed 
axonal processes per cell of approximately 150 µm regardless of IL-6 concentrations.  This 
insignificant difference in the total length of processes between cells cultured without and 
with IL-6 is consistent with the result of no significant difference in cell capacitance values 
between the two conditions.   
Interestingly, the average length of TUJ1-IR processes for AHPCs cultured with IL-6 
was about 1.5-fold greater than that for cells in control condition without IL-6.  However 
total length of TUJ1-IR processes and the membrane capacitance were similar between the 
two conditions.  In the presence of IL-6, it is possible that some TUJ1-IR neurites that may 
be presumptive axons were extended while others that were destined to become dendrites 
were retracted compared to the control condition(Ferreira and Caceres 1992; Laferriere et al. 
1997; Winckler 2007).  This result suggests that IL-6 may be involved in neurite 
specification during neuronal development.  The remodeling of neurites during neuronal 
polarization (formation of axons and dendrites) is an important aspect of neuronal 
differentiation(Craig and Banker 1994; Da Silva et al. 2005).  Axons can be distinguished 
from the dendrites by the expression of distinct molecules, such as plasma membrane 
ganglioside sialidase (PMGS) found in the axon of mature neurons(Da Silva et al. 2005) and 
higher glycogen synthase kinase (GSK)-3β activity in dendrites than in axons of polarized 
hippocampal neurons(Jiang et al. 2005).  Immunocytochemically TUJ1 (class III β-tubulin) is 
commonly used as an axonal marker(Joshi and Cleveland 1989; Lee et al. 1990).  Our result 
demonstrating longer average length of TUJ1-IR neurites of AHPCs cultured with IL-6 than 
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without IL-6, with no effect on total TUJ-IR neurite length, suggests that IL-6 presumably 
facilitated axonal specification.  However it remains to be elucidated how IL-6 influences the 
selection of neurites to be remodeled in conjunction with microtubule reorganization(Cao et 
al. 2006; Hakkoum et al. 2007; Zhang et al. 2007).         
AHPCs differentiating along a neuronal path exhibited two kinds of macroscopic 
conductances - sustained outward currents (sensitive to TEA, which blocks delayed 
rectifying potassium channels) and transient inward currents.  Our electrophysiological data 
demonstrate that the presumed Na
+
 current density of AHPCs cultured in the presence of IL-
6 was 2-fold greater than that in the absence of IL-6, whereas there was no significant 
difference in K
+
 current density between the two conditions; co-culture with astrocytes at 6-7 
DIV, in contrast, significantly amplified K
+
 current density 2.5-fold and appeared to increase 
Na
+
 current density 1.7-fold although this difference was not statistically significant.  This 
result suggests that IL-6 application may selectively enhance expression of voltage-gated Na
+
 
currents and that other astrocyte products may enhance the K
+
 currents.   
During rapid current clamp recording, depolarizing current steps failed to trigger 
action potentials, although slow regenerative events (maximal rate of depolarizing phase, < 
12 V/s) with modest amplitude were elicited.  The maximal slope of the upswing is set by the 
Na
+
 current density, which was about 10-fold lower in AHPCs than in mature granule cells of 
the dentate gyrus(van Praag et al. 2002), which are thought to arise from AHPCs in vivo.  
Steady-state inactivation of the Na
+
 current is also sufficiently depolarized to limit 
availability of Na
+
 current from the resting potential in some cells including glia(Barres et al. 
1989).  Detailed biophysical and molecular characterization of Na
+
 channels induced by IL-6 
awaits further study.  
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AHPCs are multipotent NPCs in the hippocampus thought to give rise to mainly 
granule cells and possibly glial cells in the dentate gyrus(Gage et al. 1998; Namba et al. 
2005).  In rodent hippocampi, NPCs expressing PSA-NCAM and GFP driven by a Nestin 
promoter undergo biphasic changes in input resistance upon commitment and maturation 
along the neuronal lineage; neural progenitors in the subgranular zone have a low Rin (< 100 
MΩ), restricted progenitors and immature granule cells a high Rin (~ 4 GΩ) and mature 
granule cells a 20-fold lower Rin of ~ 200 MΩ(Overstreet-Wadiche and Westbrook 2006; 
Schmidt-Hieber et al. 2004).  AHPCs cultured under proliferation or differentiation 
conditions, without or with IL-6, had Rin values > 2 GΩ.  By this criterion AHPCs are 
consistent either with cells that have committed to a neuronal lineage or with lineage-
restricted progenitors.  
AHPCs that have differentiated in response to IL-6 may also be at an ‘intermediate’ 
stage of neuronal and glial differentiation (as bipotent ‘neuro-glial’ precursors).  Past studies 
have reported that O2A glial precursors(Barres et al. 1990), type-1 and type-2 
astrocytes(Barres et al. 1989) and immature hippocampal astrocytes(Sontheimer et al. 1991) 
express sodium currents that are comparable to those in neurons.  However, based on our 
immunocytochemical results and the striking morphological differences between neuronal 
and glial cells, it is unlikely that recordings were made from AHPCs differentiating into 
astrocytes because only a few cells express GFAP in our culture system (< 2%) and their 
morphology is clearly distinguishable from the other cell types.  In addition, it is not likely 
that the AHPCs examined in this study were oligodendrocytes because the capacitance that is 
normally measured in oligodendrocytes is much greater than 10 pF(Barres et al. 1990).   
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Conclusion 
Soluble factors secreted from rat hippocampal astrocytes promoted neuronal 
differentiation of multipotent AHPCs.  Under non-contact co-culture conditions, the 
percentage of AHPCs expressing a neuronal marker, TUJ1, was dramatically increased 
compared to that when cultured alone without astrocytes.  In addition to the neuronal 
morphology, AHPCs under non-contact co-culture conditions developed membrane 
properties that are consistent with those of differentiated neurons.  When the AHPCs were 
cultured in the presence of exogenous IL-6, a candidate for a neurogenic astrocyte-derived 
soluble factor, the percentage of TUJ1-IR AHPCs was significantly greater than that in the 
absence of IL-6.  Moreover, AHPCs cultured with IL-6 developed a subset of neuronal-like 
membrane properties at an early time point.  These results suggest that IL-6 is an astrocyte-
derived cytokine that can induce neuronal differentiation of the AHPCs.    
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Tables 
 
Table 1.  Passive membrane properties of AHPCs cultured alone or under non-contact co-culture conditions 
 
DIV, days in vitro; RMP, resting membrane potential; Cm, cell capacitance; mV, millivolt; pF, picofarad; pA, picoampere 
 
#
, Current densities were calculated by normalizing the peak currents to the membrane capacitance. 
*
, Maximum outward currents were measured at +60 mV-step depolarization for 100 milliseconds in voltage-clamp mode (holding 
potential, VH = -100mV). 
 
a
, 
b
, 
c
, 
d
, 
e
 and 
f
, Statistically significant difference (p < 0.05,  t test) 
 
Culture condition 
N 
(cells) 
Apparent  
RMP 
(mV) 
Cm 
(pF) 
Outward current 
density 
#
 
(pA
*
/pF) 
Inward current 
density 
(pA/pF) 
AHPCs  
alone 
Proliferation 
(3-4 DIV) 
14 -71.1 ± 4.5 12.6 ± 1.3   42.5 ±   7.9 
a,b
   -3.7 ± 1.0 
d,e
 
Differentiation 
(6-7 DIV) 
22 -79.6 ± 5.0 10.9 ± 0.7 47.6 ±   6.0 
c
 -6.6 ± 1.5 
f
 
AHPCs  
in NCCC 
Differentiation 
(6-7 DIV) 
19    9.9 ± 0.8 120.9 ± 18.1 
a,c
 -10.9 ± 2.7 
d,f
 
Differentiation 
(9-10 DIV) 
11 -85.8 ± 5.1   9.9 ± 1.0   92.2 ± 26.0 
b,o
 -17.0 ± 9.0 
e,o
 
1
0
6
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Table 2.  Passive membrane properties of AHPCs cultured in the absence or presence of IL-6 (1 ng/ml) 
 
a
, Statistically significant difference (p < 0.05,  t test) 
 
 
 
 
 
 
Culture condition 
N 
(cells) 
Apparent  
RMP 
(mV) 
Cm 
(pF) 
Outward current 
density 
(pA/pF) 
Inward current 
density 
(pA/pF) 
Differentiation 
(6-7 DIV) 
− IL-6 22 -79.6 ± 5.0 10.9 ± 0.7 47.6 ± 6.0   -6.6 ± 1.5 
a
 
+ IL-6 21 -82.1 ± 4.3 12.9 ± 1.8 47.8 ± 6.0 -13.1 ± 3.3 
a
 
1
0
7
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Figure Legends 
 
Figure 1.  Differentiation of AHPCs under non-contact co-culture conditions (NCCC).  
AHPCs were cultured under four different culture conditions: (1) AHPCs cultured alone 
without astrocytes (AHPCs alone), (2) non-contact co-culture with astrocytes isolated from 
cerebral hemispheres of neonatal rat brain (NCCC with Brain-Astro), (3) non-contact co-
culture with cortical astrocytes (NCCC with CTX-Astro) and (4) non-contact co-culture with 
hippocampal astrocytes (NCCC with HC-Astro).  Differentiation of AHPCs was 
characterized using cell-type specific antibodies: TUJ1 for young neurons, RIP for 
oligodendrocytes and GFAP for astrocytes.  Values represent the average percentage of 
AHPCs immunolabeled by each antibody.  N (number of independent experiments) = 6 for 
AHPCs alone and N = 3 for each NCCC.  Error bars represent standard error of the mean 
(SEM).  Asterisks represent significant difference from the control culture of AHPCs alone (t 
test; *, p < 0.05; **, p < 0.0001).  TUJ1 immunoreactivity of AHPCs under all NCCC 
conditions was significantly greater compared to AHPCs cultured alone.  The average 
percentage of TUJ1-IR AHPCs co-cultured with hippocampal astrocytes was significantly 
greater than that of the AHPCs co-cultured with cortical astrocytes.  The RIP-IR AHPCs 
were significantly increased only when the AHPCs were co-cultured with Brain-Astro, 
compared to the AHPCs cultured alone or co-cultured with either CTX-Astro or HC-Astro. 
The percentage of GFAP-IR AHPCs did not vary significantly under these conditions.   
 
Figure 2.  Comparison of electrophysiological properties of AHPCs cultured alone or co-
cultured with neonatal astrocytes.  AHPCs with neuronal-like morphologies were selected for 
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whole cell recording in voltage-clamp mode.  (A) AHPCs cultured in the absence of 
astrocytes under differentiation condition.  (A1) A superimposed image of TUJ1-IR shown in 
red, GFP in green and DAPI-stained nuclei in blue.  (A2) A representative whole cell 
recording trace showing sustained outward currents and small transient inward currents 
elicited by a family of depolarizing voltage steps (inset, magnified inward currents).  (B) 
AHPCs co-cultured with astrocytes.  (B1) A superimposed image of TUJ1-IR AHPCs.  (B2) 
A representative trace displaying sustained outward currents and substantial transient inward 
currents.  Scale bars in (A1) and (B1) represent 20 µm. 
 
Figure 3.  Interleukin (IL)-6 enhances expression of neuronal marker protein in AHPCs.  (A) 
Average percentages ( SEM) of cell-type specific antibody labeling of AHPCs under three 
different NCCCs in the presence of goat anti-IL-6 neutralizing antibody (Anti-IL-6) or non-
specific IgG produced from goat (goat IgG) as a control.  Goat IgG was added at an equal 
concentration of Anti-IL-6 added (10 ng/ml).  With addition of Anti-IL-6 to the hippocampal 
NCCC, TUJ1-IR AHPCs were significantly decreased (54.4% in control and 51.5% with 
goat IgG vs. 27.7% with Anti-IL-6).  The blocking antibody had no effect on TUJ1 
immunoreactivity in cortical NCCC (34.2% in control and 34.4% with goat IgG vs. 35.2% 
with Anti-IL-6).  N (number of independent experimental sessions) = 3 for each co-culture 
session.  Asterisks represent statistical difference at p < 0.05.  NS, no significant difference.  
(B) Recombinant rat IL-6 (20 ng/ml) specifically induced neuronal differentiation of AHPCs 
(increased percentage of TUJ1 immunoreactivity).  N = 6.  The double asterisks represent a 
significant difference from the control culture (AHPCs alone) at p < 0.0001.  The percentage 
of TUJ-IR AHPCs was significantly greater when cultured in the presence of purified IL-6, 
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compared to that in the absence of IL-6 (38.5% with IL-6 vs. 13.1% without IL-6).  Addition 
of Anti-IL-6 blocking antibody dramatically reduced the percentage of TUJ1-IR AHPCs 
when cultured with IL-6.  (C) IL-6 enhanced primary neurite growth.  AHPCs were cultured 
under differentiation condition for 6 days in the presence of various concentrations of 
purified IL-6 from 0 to 100 ng/ml (see ‘IL-6 treatment’ in ‘Methods and Materials’ section).  
The average length of primary neurites emanating from a TUJ1-IR AHPC was measured.  
From each condition of an experimental set, 17 to 23 TUJ1-IR AHPCs were analyzed.  N = 3 
independent experiments.  Values are mean ± SEM.  Asterisks indicate statistical difference 
(t test; *, p < 0.05; **, p < 0.0001).    
 
Figure 4.  IL-6 promotes the development of sodium currents in AHPCs undergoing 
differentiation.  AHPCs were cultured alone without astrocytes under differentiation 
condition in the absence (A) or presence (B) of IL-6.  AHPCs cultured in the presence of IL-
6 developed membrane properties consistent with those of functional neurons.  The AHPCs 
possessing neuronal morphologies were analyzed using whole cell patch clamping.  (A) 
AHPCs cultured without IL-6.  (A1) A superimposed image of TUJ1-IR AHPCs shown in 
red, GFP in green and DAPI-stained nuclei in blue.  (A2) A representative family of traces 
showing TEA-sensitive sustained outward currents and very small transient inward currents 
elicited by depolarizing voltage steps (inset, magnified inward currents).  (B) AHPCs 
cultured with IL-6.  (B1) A superimposed image of TUJ1-IR AHPCs.  (B2) A representative 
traces showing TEA-sensitive outward currents and larger TTX-sensitive, transient inward 
currents. (C) IV-plot showing the relationship between stimulating voltage and current 
density.  (Upper) Recording showing TEA-sensitive outward currents (N = 5).  (Lower) 
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Recording showing TTX-sensitive inward currents (N = 3).  Scale bars in (A1) and (B1) 
represent 20 µm. 
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Figure 1.  Differentiation of AHPCs under non-contact co-culture conditions (NCCC).   
  
113 
 
Figure 2.  Comparison of electrophysiological properties of AHPCs cultured alone or co-
cultured with neonatal astrocytes.   
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Figure 3.  Interleukin (IL)-6 enhances expression of neuronal marker protein in AHPCs.  
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Figure 4.  IL-6 promotes the development of sodium currents in AHPCs undergoing 
differentiation.   
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Supporting information 
 
Supplementary Materials and Methods 
Cell culture 
All animal procedures were conducted in accordance with and had the approval of the 
Iowa State University Committee on Animal Care.  Astrocytes were isolated from cerebral 
cortices and hippocampi of postnatal day two Sprague-Dawley rat brains as described 
previously(Parpura et al. 1994; Parpura et al. 1993; Recknor et al. 2004).  Briefly, rats were 
deeply anesthetized with halothane.  Cerebral hemispheres were dissected and hippocampal 
regions were separated from the cerebral cortex.  Cortical and hippocampal tissues were 
placed in separate conical tubes and enzymatically-treated using papain (20 IU/ml; Sigma-
Aldrich, Saint Louis, MO) in Earle’s Balanced Salt Solution (EBSS; Gibco BRL, 
Gaithersburg, MD) for 1 hour in a culture incubator (37C, 5% CO2 / 95% humidified air 
atmosphere).  The digested tissues were rinsed in EBSS and then mechanically dissociated in 
astrocyte maintenance medium (see below) using a 5-ml serological pipet.  Dissociated cells 
were grown to confluence in 25 cm
2
 tissue culture flasks (T-25; Falcon) in a culture 
incubator.  Astrocytes were maintained in modified minimal essential medium (modified 
MEM) composed of MEM (Gibco), 40 mM glucose (Sigma), 2 mM L-glutamine (Gibco), 1 
mM sodium pyruvate (Sigma-Aldrich), 14 mM sodium bicarbonate (Fisher Scientific), 
penicillin/streptomycin (100 IU/ml and 100 µg/ml, respectively; Sigma-Aldrich), and 10% 
v/v , pH 7.35(Parpura et al. 1994; Parpura et al. 1993).  To ensure purification of an enriched 
population of type-1 astrocytes, cultures were screened with an anti-glial fibrillary acidic 
protein (GFAP) antibody (see ‘Immunocytochemistry’ section below).  Astrocyte 
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populations used in this study were greater than 95% immunoreactive for GFAP and no 
immunostainings for oligodendrocytic (RIP immunoreactivity) or neuronal (TUJ1 
immunoreactivity) cell-types were observed.  The astrocytes were passaged up to 5 times.  
Adult hippocampal progenitor cells (AHPCs; a gift from F. Gage, Salk Institute, La 
Jolla, CA), originally isolated from the brains of adult Fischer 344 rats and infected with 
retrovirus to express enhanced green fluorescent protein (GFP)(Gage et al. 1995; Ray et al. 
1995) were maintained as described previously(Oh et al. 2009; Recknor et al. 2006).  Briefly, 
AHPCs were maintained in 75 cm
2
 tissue culture flasks (T-75; Fisher Scientific, Pittsburgh, 
PA) coated with poly-L-ornithine (10 µg/ml; Sigma-Aldrich) and purified mouse laminin I (5 
µg/ml; R&D Systems, Inc., Minneapolis, MN).  The maintenance medium for AHPCs 
included Dulbecco’s modified Eagle’s medium/Ham’s F-12 (DMEM/F-12, 1:1; Omega 
Scientific, Tarzana, CA), 2.5 mM L-glutamine, 1x N2 supplement (containing 100 mg/L 
human transferrin, 5 mg/L recombinant insulin, 6.3 µg/L progesterone, 16.11 mg/L 
putrescine and 5.2 µg/L selenite; Gibco BRL), and 20 ng/ml basic fibroblast growth factor 
(human recombinant bFGF; Promega Corporation, Madison, WI).  For in vitro analysis, the 
AHPCs were detached from the T-75 flask using 0.05% Trypsin-EDTA (Gibco BRL), 
harvested by centrifugation at 1000g for 5 minutes, and resuspended in differentiation 
medium (i.e. maintenance medium without bFGF).  AHPCs (95 cells/mm
2
) were plated on 
polystyrene substrates coated first with poly-L-lysine (100 µg/ml) and then purified laminin I 
(10 µg/ml) and maintained in appropriate culture media.  Culture media were replenished 
every other day by removing one-half the volume of media and adding an equal volume of 
fresh media.  
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As a cellular control, fibroblasts were isolated from 0.5 cm
2
 of skin biopsies from 
postnatal day 2 rats (including epidermal and dermal layers), which were first rinsed in EBSS 
then minced with forceps.  The resulting skin tissue fragments were digested in 0.1% trypsin 
(from bovine pancreas; Sigma-Aldrich) in EBSS.  After 15 min incubation at 37°C, tissues 
were rinsed in EBSS and mechanically dissociated by triturating in modified MEM with 10% 
FBS.  Cells derived from a piece of skin were grown in a monolayer in a T-25 flask.  Cells 
were fed every 4 days by refreshing 70% v/v of media and maintained in the culture 
incubator.  Before being used in experiments, cells were passaged up to 2 times.     
 
Astrocyte-AHPC co-culture  
Transwell

 inserts (Corning, Inc., Corning, NY) were used to establish co-cultures of 
astrocytes and AHPCs growing together in the absence of physical contact (referred to as 
non-contact co-culture, NCCC) as described previously(Oh et al. 2009).  Briefly, astrocytes 
were plated on the semi-porous polyester membrane inserts inside the wells of 6-well plates 
(Corning, Inc.) at an initial cell density of 95 cells/mm
2
 and cultured in astrocyte 
maintenance medium [modified minimal essential medium (MMEM) including 10% fetal 
bovine serum (FBS; Atlanta Biologicals, Inc., Lawrenceville, GA)].  After 2 days, the 
MMEM was replaced with co-culture media, a 1:1 mixture of MMEM without FBS and 
AHPC differentiation media, following rinses with EBSS.  The AHPCs at the same cell 
density as the astrocytes were plated on polystyrene substrates coated first with poly-L-lysine 
(100 µg/ml; Sigma-Aldrich) and then purified laminin I (10 µg/ml; R&D Systems, Inc., 
Minneapolis, MN), and allowed to attach onto the substrates for 1 h.  The AHPCs seeded on 
the substrates were then placed at the bottom of each well, and the inserts with astrocytes 
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were placed inside the well, above the AHPCs.  Under these conditions, AHPCs are 
separated from direct contact with astrocytes but soluble factors released from astrocytes or 
AHPCs can diffuse through the 0.4 µm pores in the membrane insert.  After 6 days, cells 
were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for immunocytochemistry.   
 
Immunocytochemistry 
AHPCs cultured on laminin-coated substrates were processed for 
immunocytochemistry according to standard protocols described previously(Oh et al. 2009; 
Recknor et al. 2006).  Fixed AHPCs were labeled with antibodies against phenotypic markers, 
class III β-tubulin (TUJ1, mouse monoclonal IgG; R&D Systems) diluted at 1:750 to a final 
concentration of 1.3 µg/ml, receptor interacting protein [RIP in concentrated form supplied 
by vendor, mouse monoclonal IgG; developed by Susan Hockfield; obtained from the 
Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and 
maintained by The University of Iowa (Iowa City, IA)] diluted at 1:1,500 and glial fibrillary 
acidic protein (GFAP, mouse monoclonal IgG; Lab Vision Corp., Fremont, CA) diluted at 
1:2,000 to a final concentration of 0.5 µg/ml.  Biotinylated donkey anti-mouse secondary 
antibody and Cy3-conjuated streptavidin (Jackson ImmunoResearch, West Grove, PA) were 
used at final concentrations of 4 µg/ml and 120 ng/ml, respectively, for visualizing the 
primary antibody labeling.  Nuclei were counterstained with 1 µM 4’, 6-diamidino-2-
phenylindole, dilactate (DAPI).  Preparations were then mounted onto microscope slides 
using GelMount antifade mounting medium (Biomeda Corp., Foster City, CA). 
The preparations were examined and photographed using an upright fluorescence 
microscope (Nikon Microphot FXA) equipped with a Retiga 2000R digital camera controlled 
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by QCapture software (QImaging, Surrey, BC, Canada).  For image analysis, six to eight 
microscope fields from each substrate were taken randomly using a 20X objective.  Each 
field represents 0.17 mm
2
 (476 µm x 357 µm).  To calculate the percentage of 
immunoreactive AHPCs on each substrate, the number of cells immunoreactive for each 
antibody was divided by the total number of cells (DAPI-stained nuclei).   
 
Neurite outgrowth assay 
AHPCs were cultured in the absence or presence of purified IL-6 at different 
concentrations (from 0.00001 to 100 ng/ml; Figure 3 C) for 6 days.  After fixation, cultured 
AHPCs were immunolabeled for TUJ1 and imaged using a 40X objective.  From the images, 
17 to 22 TUJ1-immunoreactive AHPCs per condition were analyzed for the length of 
neurites emanating from the cell body using ImageJ, image processing and analysis program 
(developed at the National Institutes of Health, http://rsbweb.nih.gov/ij/).  Cells we classified 
as TUJ1-immunoreactive possessed some neurites that were and others that were not 
immunoreactive for TUJ1; only TUJ1-immunoreactive neurites were examined.  TUJ1 is 
found in neurites committed to become axons in young neurons(Joshi and Cleveland 1989; 
Lee et al. 1990).  To calculate the average neurite length per cell, total length of TUJ1-
immunoreactive neurites of each cell, measured from the edge of the cell body to the tip of 
the TUJ1-immunoreactive neurite, was divided by the number of the TUJ1-immunoreactive 
neurites.  Secondary neurites branching from the primary neurites were not included in this 
analysis.  Neurites that appeared to originate from neighboring cells, although touching the 
target cell, were also excluded from the measurement.  Three independent experiments were 
analyzed for each condition.  
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Quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) 
Total RNA was extracted using Nucleospin® RNA II Total RNA Isolation kit 
(Macherey-Nagel, Düren, Germany), treated with RNase-free rDNase (Macherey-Nagel) for 
15 min at 23˚C then reverse transcribed by Superscript III™ reverse transcriptase (Invitrogen, 
Carlsbad, CA).  The resulting samples were prepared for qPCR in a 25 l volume containing 
25 mM KCI, 10 mM Tris-HCI (pH 8.4), 0.1 mM dNTP, 12.5U/ml iTaq DNA polymerase, 
1.5 mM MgCI2, iQ™ SYBR® Green I, 5 nM fluorescein, stabilizers (Cat # 170-8880, Bio-
Rad Laboratories, Inc., Hercules, CA), the appropriate primers at 0.5 M each,and cDNA 
template as defined by the experiment.  The qPCR was performed using an Opticon 
thermocycler (MJ Research, Inc., Waltham, MA, model CFD-0200) using a  95˚C for 5 min 
premelt followed by 39 cycles of 95˚C 10 sec, 60˚C 30 sec and including a final 
determination of melting curves from 65˚C to 90˚C.  The primer sequences for the genes 
examined were as follows: IL-6, AATCTGCTCTGGTCTTCTGGAGT, TTG-
CCGAGTAGACCTCATAGTGA; IL-6Rα, CGAGGGAAGGAGGAGTTTGA, 
GATGATGAAGACACAGAGAAGCAAT; sIL-6Rα, TCCCTCTCCAACCACGAA, 
ACACTTTGTCACCCTCCA; gp130, ATTAAGGAGAATGGGAAGGG, 
TACATAGCGGTTATTGGTGAG; Cyclophilin A, TGTTCTTCGACATCACGGCTGAT, 
GGACTTGCCACCAGTGCCATTA.  The amount of each mRNA was quantified by using a 
standard curve evaluated in the same qPCR run using a series of known dilutions of 
amplified fragments of the target gene.  Values that were above or below the range of the 
standards were not included for the analysis and the affected samples were reanalyzed at 
dilutions to ensure that the values were within the range of the standard curve.   
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Enzyme-linked immunosorbent assay (ELISA) 
AHPCs were cultured alone or co-cultured with either astrocytes or skin-derived 
fibroblasts without physical contact.  All cultures were maintained in co-culture media (see 
‘Astrocyte-AHPC co-culture’ section above).  At 2 and 4 days after culture establishment, 
co-culture media in which all cultures were maintained (referred to as conditioned co-culture 
media) were collected for ELISA.  The concentrations of IL-6 protein secreted into the 
conditioned co-culture media were determined using an ELISA kit (Quantikine Rat IL-6 
Immunoassay; R&D Systems) according to the manufacturer’s protocol.  Each condition was 
analyzed in duplicate.  The concentration of secreted IL-6 was calculated by extrapolation 
from the standard curves generated using rat recombinant IL-6 contained in the assay kit.  
Three independent experiments were performed for the cultures of AHPCs alone and co-
cultures of AHPCs and astrocytes.  Two independent experiments were analyzed for co-
cultures of AHPCs and fibroblasts. 
 
 
Supplementary Results and Discussion 
Versatile roles of IL-6 in the central nervous system  
IL-6 is recognized by the high-affinity receptor (IL-6R) which is expressed on target 
cells(Scheller and Rose-John 2006; Van Snick 1990).  There are two forms of the IL-6R, one 
transmembrane and the other (sIL-6R) being soluble.  The latter is believed to be more 
important for neural signaling(Marz et al. 1999b).  Both bind to IL-6 and the IL-6/IL-6R 
complex interact with gp130, which is a general receptor for the IL-6 family cytokines(Jones 
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et al. 2005; Taga and Kishimoto 1997).  Gp130, a 130 kD non-ligand-binding membrane 
glycoprotein, does not bind directly to IL-6(Hibi et al. 1990; Taga et al. 1989).  The 
association of IL-6/IL-6R complex with gp130 causes auto-phosphorylation of the gp130 
dimer followed by activation of the Janus kinases (JAKs)(Jones et al. 2005).  The activation 
of JAK/STAT, Ras/ERK or other signal transduction pathways results in the modulation of 
various genes that control neural development(Gadient and Otten 1994; Gruol and Nelson 
1997; Heinrich et al. 2003; Marz et al. 1997; Taga and Fukuda 2005).   
Through the JAK/STAT pathway, IL-6 has been implicated in induction of glial 
differentiation from NPCs in the mammalian brain(Bonni et al. 1997; Islam et al. 2008; Taga 
and Fukuda 2005).  Recent studies examining inflammatory responses mediated in part by 
cytokines, including IL-6, on hippocampal neurogenesis showed that IL-6 production from 
activated microglia interferes with the generation of new neurons in the hippocampus of the 
adult brain(Ekdahl et al. 2003; Monje et al. 2002; Monje et al. 2003).  Thus far, the role of 
IL-6 in the neurogenic niche has been suggested to be inhibition of neurogenesis via a 
decrease in NPC proliferation or an increase in glial differentiation, both depleting the pool 
of NPCs.  However, a number of studies have shown that IL-6, in conjunction with IL-6R, 
can also exert neurotrophic effects(Gadient and Otten 1997; Marz et al. 1999a; Schafer et al. 
1999; Thier et al. 1999).  By stimulating region-specific astrocytes to provide local 
supplements of neurotrophins (NTs), IL-6 facilitates neuronal survival(Marz et al. 1999a).  In 
addition, IL-6 with IL-6R (especially the soluble form) induces neuronal-like differentiation 
of PC12 cells(Marz et al. 1997) and contributes to the regeneration of axotomized mature 
sensory or hippocampal neurons(Cao et al. 2006; Hakkoum et al. 2007; Hirota et al. 1996).  
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Therefore the effects of IL-6 on NPC differentiation or survival appear to be context-
dependent.   
 
IL-6 is produced from the co-cultured astrocytes  
To quantify the amount of IL-6 protein secreted into the culture media, we performed 
enzyme-linked immunosorbent assays (ELISA).  Five different culture conditions were 
established: (1) AHPCs cultured alone, (2) cortical astrocytes cultured alone, (3) co-culture 
of AHPCs and cortical astrocytes, (4) hippocampal astrocytes cultured alone, and (5) co-
culture of AHPCs and hippocampal astrocytes.  In addition, as a cell control, skin-derived 
fibroblasts were cultured alone as well as co-cultured with AHPCs in parallel with the other 
cultures.  All seven culture conditions were maintained for 4 days.  Conditioned co-culture 
media from the seven cultures were collected at 2 and 4 DIV.  The conditioned medium from 
each culture condition was examined for the amount of IL-6 secreted from the cultured cells.   
Supplementary Figure 3 A demonstrates that, when cultured alone, the AHPCs 
secreted relatively low levels of IL-6 (average of 2.6 pg/ml) while both cortical and 
hippocampal astrocytes produce approximately 88 pg/ml and 70 pg/ml, respectively.  In 
addition, a comparable level of IL-6 was detected from both co-cultures of AHPC-cortical 
astrocytes and AHPC-hippocampal astrocytes (Supplementary Figure 3 A).  Statistical 
analysis showed that there were no significant differences in the amounts of IL-6 in the 
medium of cortical or hippocampal astrocytes cultured alone or in co-cultures with AHPCs.  
These results demonstrate that (a) the major source of IL-6 production in the non-contact co-
culture system is the astrocytes, rather than AHPCs, and (b) the IL-6 production capability of 
astrocytes appears to be independent of the AHPCs co-cultured with them.   
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Recently, it was reported that rat hippocampal and cortical astrocytes displayed 
distinct gene expression profiles(Barkho et al. 2006).  Moreover, IL-6 mRNA was shown to 
be highly expressed in hippocampal astrocytes and exogenous application promoted neuronal 
differentiation of NPCs(Barkho et al. 2006).  Our results are consistent with these and our 
ELISA results further demonstrated that both hippocampal and cortical astrocytes produce 
over 2.5-times more IL-6 than the AHPCs.  Moreover, the amount of IL-6 present in the 
media from co-cultures (AHPC-cortical astrocyte or AHPC-hippocampal astrocyte) was 
comparable to that in medium from the astrocytes cultured alone.  There was no significant 
difference in terms of the secreted IL-6 level between the astrocyte alone cultures and the co-
cultures of AHPCs with hippocampal or cortical astrocytes.  These results suggest that (a) the 
astrocytes used for this study are capable of expressing and releasing IL-6 and (b) the 
extracellular IL-6 protein is not likely to be regulated by the co-cultured AHPCs.  However, 
the level of IL-6 mRNA was considerably increased in hippocampal astrocytes that were co-
cultured with AHPCs.  It is possible that the hippocampal astrocytes produce more IL-6 
when co-cultured with AHPCs, but as part of their response to the IL-6, the AHPCs bind and 
take it up by way of the IL-6R and gp130 receptor complex leaving approximately the same 
amount of IL-6 in the medium as seen for astrocytes cultured alone. 
To examine the expression levels of IL-6, its specific receptor, IL-6R 
(transmembrane and soluble) and gp130 in AHPCs and astrocytes, all seven different culture 
conditions [see above, culture number (1) through (5) and fibroblast cultures (alone and in 
co-culture)] were established.  The cultures were maintained in co-culture media for 5 days.  
The IL-6 and IL-6R mRNA levels in AHPCs and astrocytes or fibroblasts were analyzed by 
RT-qPCR.  Under all conditions, AHPCs expressed IL-6 mRNA at a much lower level than 
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did astrocytes; cortical and hippocampal astrocytes expressed 260- and 280-fold more, 
respectively, than did AHPCs (Supplementary Figure 3 B).  This result is consistent with the 
observed IL-6 protein levels in the medium of these cell types.  By comparison with IL-6 
mRNA levels, IL-6R and gp130 mRNA expression levels did not vary greatly between cell 
types (Supplementary Figure 3 C).   
When in co-culture with AHPCs, the level of IL-6 mRNA was higher in cortical and 
hippocampal astrocytes (approximately 4- and 7-fold, respectively) than when they were 
cultured alone.  Higher IL-6 mRNA levels were not observed in fibroblasts or AHPCs when 
co-cultured with astrocytes compared with when they were cultured alone.  Thus, it appears 
that - of these cell types - astrocytes are uniquely responsive to secretions of AHPCs to 
increase the levels of IL-6 gene expression.  This result demonstrates that astrocytes 
synthesize and secrete IL-6 and that both astrocytes and AHPCs express the genes encoding 
the receptors necessary for responding to IL-6.      
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Supplementary Table 1.  Average number of TUJ1-IR processes emanating from TUJ-IR AHPCs cultured with various 
concentrations of exogenous IL-6 
 
 
 
Conc of IL-6 
(ng/ml) 
# of processes 
0 0.00001 0.0001 0.001 0.01 0.1 1 10 100 
Average 3.90 4.16 4.08 4.11 4.26 3.99 4.16 4.25 4.44 
SEM 0.61 0.57 0.46 0.19 0.31 0.15 0.45 0.39 0.29 
1
3
2
 
 
  
133 
Supplementary Figure Legends 
 
Supplementary Figure 1.  Dose-dependent effect of IL-6 on AHPC neuronal differentiation.   
AHPCs were cultured under differentiation conditions for 6 days in the presence of different 
concentrations of purified IL-6 (0, 0.00001, 0.0001, 0.001, 0.01, 0.1, 1, 10 and 100 ng/ml).  
The percentages of TUJ1-IR or RIP-IR AHPCs were quantitatively analyzed and averaged 
over the total number of cells.  N = 3 independent experimental culturing sessions.  Error 
bars represent standard error of the mean (SEM).  Asterisks represent a significant difference 
from the controls at 0 ng/ml (p < 0.05, t test).  The percentages of TUJ1-IR AHPCs cultured 
in the presence of concentrations of IL-6 greater than 0.1 ng/ml were significantly increased, 
compared to the control cultures (0 ng/ml of IL-6).  No significant differences in RIP 
immunoreactivity were observed at any IL-6 concentrations. 
 
Supplementary Figure 2.  Total length of processes per a TUJ1-IR AHPC.  AHPCs were 
cultured in the presence of various concentrations of IL-6 from 0 to 100 ng/ml (0, 0.00001, 
0.0001, 0.001, 0.01, 0.1, 1, 10 and 100 ng/ml conditions).  For each TUJ1-IR cells, the length 
of every process was measured and total length of all primary processes from the cell was 
calculated.  In each condition, 17 to 23 TUJ1-IR AHPCs were analyzed.  The total length of 
all processes was averaged and three independent experimental sets were analyzed (N = 3).  
Values are mean ± SEM.  There was no significant difference among the conditions.   
 
Supplementary Figure 3.  IL-6 proteins are secreted from the astrocytes.  AHPCs were 
cultured alone or co-cultured with either cortical or hippocampal astrocytes without physical 
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contact.  (A) The amount of secreted IL-6 proteins into the culture medium was assayed 
using an ELISA assay.  Seven different culture conditions were established in parallel: (1) 
AHPCs cultured alone, (2) cortical astrocytes cultured alone, (3) co-culture of AHPCs and 
cortical astrocytes, (4) hippocampal astrocytes cultured alone, (5) co-culture of AHPCs and 
hippocampal astrocytes, (6) skin-derived fibroblasts cultured alone, and (7) co-culture of 
AHPCs and skin-derived fibroblasts.  Conditioned culture media from every culture 
condition were collected.  When AHPCs were cultured alone, approximately 2.6 pg/ml of IL-
6 was measured from the conditioned culture medium.  Cortical and hippocampal astrocytes 
produced approximately 88 pg/ml and 70 pg/ml, respectively.  From both co-cultures of 
AHPC-cortical astrocyte and AHPC-hippocampal astrocyte, approximately 73 pg/ml and 72 
pg/ml of IL-6 was detected, respectively.  From the cultures of fibroblasts cultured alone and 
co-cultured with AHPC, less than 20 pg/ml of IL-6 was secreted (average amount: 15.5 
pg/ml from fibroblasts alone and 9.1 pg/ml from AHPC-fibroblast co-culture).  N = 3 for all 
culture conditions, except the conditions using skin-derived fibroblasts (N = 2).  Values are 
mean ± SEM.  Asterisks indicate statistical difference (t test; p < 0.05).  (B, C) The mRNA 
expression levels for IL-6, IL-6Rα and gp130 were normalized to the cyclophilin A mRNA 
level for each sample.  The normalized values were then calibrated within each experiment to 
the value for cortical astrocytes alone to obtain relative mRNA expression levels.  Average 
relative expression levels (Y-axis) are shown for two experiments in which two and four 
biological replicates were analyzed with two technical replicates per sample.  (B) IL-6 
mRNA, (C) IL-6Rα and gp130 mRNA. 
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Supplementary Figure 1.  Dose-dependent effect of IL-6 on AHPC neuronal differentiation. 
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Supplementary Figure 2.  Total length of processes per a TUJ1-IR AHPC.  
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Supplementary Figure 3.  IL-6 proteins are secreted from the astrocytes.   
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Abstract 
 The purpose of this study was to investigate possible molecular mechanisms through 
which interleukin-6 (IL-6) induces neuronal differentiation of adult hippocampal neural 
progenitor cells (AHPCs).  We previously reported that astroglial cells from neonatal rat 
brain produce soluble factors which enhance neuronal differentiation of AHPCs, and that IL-
6 is an  astrocyte-derived factor which specifically promotes neuronal differentiation of 
AHPCs
1, 2
.  In the present study, we examined the influence of extracellular calcium and 
voltage-gated calcium channel antagonists on IL-6-induced neuronal differentiation of 
AHPCs.  AHPCs were cultured in various concentrations of external calcium or with L-type 
voltage-gated calcium channel blockers.  Our results demonstrate that extracellular calcium 
was critical for neuronal differentiation of IL-6-treated AHPCs, that a blockage of L-type 
Cav channels inhibited IL-6-enhanced neuronal differentiation of AHPCs, and that 
exogenous IL-6 treatment increased the percentage of AHPCs immunoreactive for an 
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activated from of CREB (phosphorylated CREB).  These results suggest that IL-6 may 
induce AHPCs to commit to a neuronal lineage by promoting extracellular calcium influx 
which leads to CREB activation.  Our findings may provide insight into understanding 
injury-induced neurogenesis and have implications for developing cell-based therapeutic 
strategies using adult neural progenitor cells.   
 
 
Introduction 
Depending on the interplay between neural progenitor cells (NPCs) and their 
microenvironment, NPCs can proliferate as well as give rise to neurons or glial cells
3-5
.  We 
previously reported that astroglial cells from newborn rat brain produce soluble factors which 
enhance neuronal differentiation of adult NPCs
1
.  In addition, using immunocytochemical 
and electrophysiological approaches, we found that interleukin-6 (IL-6) may serve as an 
astrocyte-derived factor and can enhance neuronal differentiation of adult NPCs in vitro
2
.   
IL-6 is a cytokine that induces cell growth and differentiation in the hematopoietic 
and immune systems
6, 7
.  IL-6 is also found in the cerebrospinal fluid and plays a role in 
mediating inflammatory responses in the injured brain
8-10
.  Astrocytes are a major source of 
IL-6 in the brain
6, 9, 11.  In the normal brain, IL-6 is expressed at a basal level, but its 
production levels are elevated as the neural cells are infected or damaged9, 12.  In 
addition, IL-6 can function as a neurogenesis-promoting factor to promote neuronal 
differentiation of adult NPCs in vitro2, 11.  However little is known about how IL-6 
stimulates adult NPCs to commit to a neuronal lineage. 
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In NPCs of young or adult rodent brains, an increase in intracellular calcium 
concentration is important for membrane depolarization-dependent neuronal differentiation
13-
17
.  L-type Cav channels and N-methyl-D-aspartic acid (NMDA) receptors have been 
reported to modulate NPC neuronal differentiation by sensing membrane-depolarizing 
stimuli
14, 15, 18
.  To investigate possible mechanisms of which IL-6 promotes neuronal 
differentiation of NPCs, we examined an involvement of voltage-gated calcium (Cav) 
channels in IL-6-mediated neuronal differentiation of adult NPCs.  In this study, self-
renewing, multipotent NPCs isolated from adult rat hippocampus (referred as to adult 
hippocampal progenitor cells, AHPCs) were cultured in the absence or presence of 
exogenous IL-6.  To antagonize Cav channels, the dihydropyridines nifedipine or isradipine 
were used.  Neuronal or glial differentiation of AHPCs and the activation of a transcription 
factor (cAMP response element binding protein, CREB) induced by external calcium influx 
were examined by immunocytochemical analyses.  
 
 
Materials and Methods 
Neural progenitor cell culture 
Adult hippocampal progenitor cells (AHPCs from F. Gage, Salk Institute, La Jolla, 
CA), isolated from the brains of adult Fischer 344 rats and infected with retrovirus to express 
enhanced green fluorescent protein (GFP)
19-21
, were maintained as described previously
1, 2
.  
Briefly, AHPCs were maintained in 75 cm
2
 tissue culture flasks (T-75; Fisher Scientific, 
Pittsburgh, PA) coated with poly-L-ornithine (10 µg/ml; Sigma-Aldrich) and purified mouse 
laminin I (5 µg/ml; R&D Systems, Inc., Minneapolis, MN).  The maintenance medium for 
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AHPCs included Dulbecco’s modified Eagle’s medium/Ham’s F-12 (DMEM/F-12, 1:1 
mixture, which contains 1.045 mM CaCl2; Omega Scientific, Tarzana, CA), 2.5 mM L-
glutamine, 1x N2 supplement (containing 100 mg/L human transferrin, 5 mg/L recombinant 
insulin, 6.3 µg/L progesterone, 16.11 mg/L putrescine and 5.2 µg/L selenite; Gibco BRL), 
and 20 ng/ml basic fibroblast growth factor (human recombinant bFGF; Promega 
Corporation, Madison, WI).  To prepare DMEM/F-12 media that contained varying 
concentrations of calcium, calcium-free DMEM and F-12 nutrient mixture containing 0.299 
mM of CaCl2 (both obtained from Gibco BRL) were mixed at an 1:1 ratio.  The final 
concentration of calcium in culture medium was adjusted with 1 M CaCl2.  Divalent cationic 
imbalance due to lowering calcium concentration in the culture medium was balanced by 
supplementing 1M MgCl2.   
For in vitro analyses, the AHPCs were detached from the T-75 flask using 0.05% 
Trypsin-EDTA (Gibco BRL), harvested by centrifugation at 1000 g for 5 minutes, and 
resuspended in differentiation medium (i.e. maintenance medium without bFGF).  AHPCs 
(100 cells/mm
2
) were plated on 12-mm diameter circular cover glass (Fisher Scientific) 
coated first with poly-L-ornithine (50 µg/ml) and then purified laminin I (10 µg/ml) and 
maintained in differentiation media.  To induce neuronal differentiation, AHPCs were treated 
with purified rat recombinant IL-6 (1 ng/ml; R&D Systems)
2
.  To neutralize IL-6, anti-IL-6 
function blocking antibody was used at 10 ng/ml.  To antagonize L-type Cav channgels, two 
dihydropyridines, nifedipine and isradipine (dissolved in dimethyl sulfoxide, DMSO) were 
used at a concentration of 1 µM and 0.5 µM, respectively (see Supplementary Figure 1 for 
concentration-dependent effects on AHPC differentiation).  Culture media were replenished 
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every other day by removing one-half the volume of media and adding an equal volume of 
fresh media including the drugs freshly made.   
 
Immunocytochemistry 
AHPCs cultured on laminin-coated substrates were processed for 
immunocytochemistry according to standard protocols described previously
1
.  Fixed AHPCs 
were labeled with antibodies against phenotypic markers, class III β-tubulin (TuJ1, mouse 
monoclonal IgG; R&D Systems), receptor interacting protein (RIP in concentrated form 
supplied by vendor, mouse monoclonal IgG; Developmental Studies Hybridoma Bank), and 
glial fibrillary acidic protein (GFAP; mouse monoclonal IgG; Lab Vision Corp., Fremont, 
CA).  Donkey anti-mouse secondary antibody, Cy3-conjugated (Jackson ImmunoResearch, 
West Grove, PA) was used for visualizing the primary antibody labeling.  For 
immunocytochemical analysis of CREB and phosphorylated CREB (pCREB) in AHPCs, 
primary antibodies against CREB or pCREB (rabbit monoclonal IgG) were obtained from 
Cell Signaling Technology, Inc. (Danvers, MA).  Donkey anti-rabbit secondary antibody, 
Cy5-conjugated (Jackson ImmunoResearch) was used for visualizing CREB or pCREB.  
Nuclei were counterstained with 1 µM 4’, 6-diamidino-2-phenylindole, dilactate (DAPI).  
Preparations were then mounted onto microscope slides using GelMount antifade mounting 
medium (Biomeda Corp., Foster City, CA).  
The preparations were examined and photographed using an upright fluorescence 
microscope (Nikon Microphot FXA) equipped with a Retiga 2000R digital camera controlled 
by QCapture software (QImaging, Surrey, BC, Canada).  For image analysis, eight to ten 
microscope fields from each substrate were taken randomly using a 20X objective.  Each 
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field represents 0.17 mm
2
 (476 µm x 357 µm).  To calculate the percentage of 
immunoreactive AHPCs on each substrate, the number of cells immunoreactive for each 
antibody was divided by the total number of cells (DAPI-stained nuclei).  The number of 
independent experiments performed was 6 for the culture of AHPCs alone and 3 for each 
non-contact co-culture. 
 
Statistical analysis 
Statistical analysis was performed using GraphPad PRISM (ver. 3.0).  All tests were 
two-tailed tests and p-values less than an alpha of 0.05 were considered significantly 
different.  
 
 
Results 
Extracellular calcium is required for IL-6-enhanced neuronal differentiation 
To examine whether extracellular calcium is necessary for neuronal differentiation of 
AHPCs in the presence of IL-6, AHPCs were cultured in differentiation medium containing 
various concentrations of extracellular calcium ([Ca]ext).  Normal AHPC culture medium, 
DMEM/F-12, contains 1.045 mM of CaCl2.  To lower the [Ca]ext, Ca-free DMEM and 
0.299 mM [Ca]-containing F-12 nutrient mixture were mixed at an 1:1 ratio.  [Ca]ext in the 
mixed medium became 0.15 mM, which was the lowest [Ca]ext examined in this experiment.  
By supplementing the mixed medium with 1 M of CaCl2, the [Ca]ext was adjusted to be 0.25, 
0.5, 1.045 (as a control), 2 and 5 mM.  For in vitro analyses, AHPCs were cultured in the 
varying [Ca]ext-containing media with or without application of IL-6 (rat recombinant IL-6, 
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1 ng/ml).  After 6 days, cells were fixed and immunolabeled.  AHPC neuronal differentiation 
was accessed by phenotypic marker expression, TuJ1 in an immunocytochemical analysis.   
When cultured in lower concentrations of [Ca]ext (< 0.5 mM), exogenous IL-6 
application failed to increase the proportion of AHPCs differentiating toward a neuronal fate, 
based on TuJ1 immunoreactivity (Figure 1 A).  In contrast, when AHPCs were cultured in 
the medium which contained a normal [Ca]ext, 1.045 mM, IL-6 application increased the 
fraction of TuJ1-immuoreactive (IR) AHPCs.  This result suggests that extracellular calcium 
is essential for IL-6-mediated neuronal differentiation of AHPCs.  In addition, we observed 
that the average number of DAPI-stained AHPCs was significantly lower in 0.15 mM or 0.25 
mM [Ca]ext-containing media, compared to the control cultures (containing a normal 
[Ca]ext) (Figure 1 B).  From propidium idodide (PI) test, we additionally observed that 
considerably more AHPCs were stained for PI when cultured in 0.15 mM [Ca]ext-containing 
medium, compared to the other conditions which contained > 0.25 mM of [Ca]ext 
(Supplementary Figure 1).  In the presence of 5 mM of [Ca]ext, the highest [Ca]ext tested in 
this study, none of cells survived (data not shown).  These results suggest that extracellular 
calcium is important for AHPC survival as well as cell adhesion onto the purified 
extracellular matrix, laminin.    
 
L-type Cav channel antagonists reduce IL-6-enhanced neuronal differentiation  
 To examine whether IL-6 treatment induces extracellular Ca influx, AHPCs were 
cultured with IL-6 as well as nifedipine or isradipine, which are both L-type Cav channel 
antagonists.  Based on the results of concentration-dependent tests (see Supplementary 
Figure 2), nifedipine and isradipine were used at 1 µM and 0.5 µM, respectively.   
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IL-6 treatment specifically increased the percentage of cells that were TuJ1-IR 
(Figure 2), which is consistent with our previous results
2
.  Moreover, the application of 
nifedipine or isradipine to the IL-6-treated cultures resulted in diminishing the fraction of 
TuJ1-IR cells, with no significant changes in the fraction of RIP-IR cells.  These findings 
suggest that Ca influx through L-type Cav channels plays a critical role to promote neuronal 
differentiation (determined by TuJ1 expression) of AHPCs in the presence of IL-6.     
 
IL-6 treatment augments the fraction of CREB-IR and TuJ1-IR AHPCs 
 An increase in intracellular calcium concentration ([Ca]i) by extracellular Ca entry 
results in rapid and acute expression of immediate early genes (such as c-fos and Jun 
family)
22-24
.  These genes are known to encode transcription factors that control cellular 
responses to synaptic stimulation during neuritogenesis and synaptic formation of neuronal 
precursors
24
.  CREB is one of the transcription factors activated when [Ca]i is elevated
25, 26
.  
To investigate possible pathways through which IL-6 induces neuronal differentiation of 
AHPCs, we examined and quantified phosphorylated CREB (pCREB) in AHPCs after 
culturing with or without IL-6.  CREB or pCREB in AHPCs was detected by monoclonal 
antibodies after termination of the culture session.   
We observed that almost all AHPCs (approximately 95%) were CREB-IR regardless 
of IL-6 application and that in the presence of IL-6, the percentage of CREB- and TuJ1-IR 
AHPCs was about 3-fold greater than that in the absence of IL-6 after 3 days in culture 
(Figure 3 A).  In addition, with IL-6 application, the fraction of pCREB-IR AHPCs was 
about 3-fold increased compared to the control culture condition (without IL-6).  Moreover, 
when AHPCs were cultured with exogenous IL-6, the fraction of pCREB- and TuJ1-IR 
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AHPCs was about 9-fold increased compared to control culture.  Interestingly, when AHPCs 
were treated with IL-6 as well as either nifedipine or IL-6 neutralizing antibody (anti-IL-6, 
IL-6 function blocking antibody), neither the fraction of only TuJ1-IR nor the fraction of 
pCREB- and TuJ1-IR AHPCs was increased.  We also examined CREB activation in AHPCs 
expressing an oligodendrocytic marker, RIP, but found no significant differences in RIP- 
and/or pCREB-IR in the comparison of IL-6-treated cultures to the control (Supplementary 
Figure 3).  
 Furthermore, ratios of the percentages of CREB or pCREB-IR AHPCs versus the 
percentages of TuJ1-IR AHPCs in the absence or presence of IL-6 were calculated (Figure 3 
B).  Results from this analysis are as follow: first, almost all AHPCs expressed CREB 
regardless of culture condition and all TuJ1-expressing AHPCs were expressing CREB.  
Second, there were about 2.4 times more TuJ1-positive AHPCs observed among all CREB-
positive AHPCs in the IL-6-treated cultures compared to the control.  Third, of TuJ1-postive 
AHPCs, about 3.3 times more pCREB-positive cells were observed in the IL-6-treated 
cultures compared to the non-IL-6-treated cultures.  Fourth, of pCREB-positive AHPCs, 
there were about 2.2 times more TuJ1-positive cells found in the IL-6-treated cultured 
compared to the control cultures.  Last but most important, although AHPCs were cultured 
with IL-6, when the cells were treated with nifedipine or anti-IL-6, the fractions of AHPCs 
immunoreactive only for TuJ1 as well as for both TuJ1 and pCREB were not increased.  
These results suggest that (1) IL-6 treatment induces AHPCs to commit to a neuronal lineage, 
(2) L-type Cav channels are involved in IL-6-induced neuronal differentiation of AHPCs and 
(3) IL-6 application facilitates CREB activation in AHPCs.  
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Discussion 
 We previously demonstrated that IL-6 is an astrocyte-derived factor that promotes 
neuronal differentiation of AHPCs in vitro
2
, and in this study report a possible mechanism of 
IL-6-enahnced neuronal differentiation of the AHPCs.  Our immunocytochemical results 
showed that extracellular calcium is essential for AHPC neuronal differentiation in the 
presence of IL-6, L-type Cav channel antagonists inhibit IL-6-mediated neuronal 
differentiation, and IL-6 treatment activates CREB in AHPCs.   
 
IL-6 and intracellular calcium rise 
 IL-6 and its receptor are expressed in postnatal rat brains (especially the hippocampus 
and cerebellum
27
) and their transcripts appear to be developmentally regulated in a region-
specific manner
28
.  However, roles of IL-6 remain controversial (i.e. neuroprotective vs 
neurotoxic
6
).  For instance, in developing cerebellar granule cells isolated from 6~8-day old 
rats, chronic exposure to IL-6 is reported to increase [Ca]i due to excessive activation of 
NMDA receptors and ends up increasing susceptibility to excitotoxic insults leading to 
neuronal loss
29-32
.  Other groups claim that treatment of neonatal rat cerebellar granule 
neurons with exogenous IL-6 prevents neuronal cell death by reducing apoptosis and keeps 
intracellular Ca from being overloaded
33, 34
.  In addition, some groups showed a 
neuroprotective effect of IL-6 on hippocampal neurons
35-38
.  Considering the variable results 
obtained from multiple studies
31, 39, 40
, the effects of IL-6 may be dependent upon neuronal 
cell type examined, the varying times/duration of IL-6 treatment, and concentrations of IL-6 
applied.  Previously, we have reported the effects of various concentrations of exogenous IL-
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6 (0.00001, 0.0001, 0.001, 0.01, 0.1, 1, 10 and 100 ng/ml) on AHPC differentiation in vitro
2
.  
From the concentration-dependent test, we observed that AHPC neuronal differentiation 
(assessed by TuJ1 immunoreactivity) was significantly increased at the concentrations of IL-
6 greater than 0.1 ng/ml compared to the control (no IL-6 added).  In addition, AHPCs 
treated with purified IL-6 which concentration was greater than 1 ng/ml developed 
significantly longer processes (measured from TuJ-IR AHPCs).  Moreover, from all culture 
conditions of different IL-6 concentrations, we observed no considerable changes in the total 
number of cells.  Thus, our previous and present results suggest that, in our culture system, 
purified IL-6 (used at a concentration of 1 ng/ml) provides neurogenic effects on AHPC 
differentiation, rather than cytotoxic effects.    
 Qiu et al. (1995) reported that IL-6 treatment caused cerebellar granule neurons to be 
more sensitive to NMDA application and increased [Ca]i when NMDA receptors were 
agonized
30
.  Moreover, NMDA-induced [Ca]i increase in IL-6-treated cells was significantly 
decreased when [Ca]ext was reduced and intracellular Ca stores were depleted
30
.  They 
further demonstrated that both calcium release from intracellular stores
29
 and Ca influx 
through L-, N- and P/Q-type Cav channels
32
 may contribute to [Ca]i rise in IL-6-treated 
neurons.  These results suggest that IL-6 renders the developing neurons more sensitive to 
membrane depolarization stimuli by increasing [Ca]i.   
   
NPC differentiation and calcium influx 
In the adult NPCs, [Ca]i can be increased by external Ca entry through Cav channels 
or NMDA receptors or by Ca release from internal Ca stores after external Ca influx.  An 
increase in [Ca]i is known to promote neuronal differentiation of NPCs in young and adult 
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rodent brains
13-16
.  Deisseroth et al. (2004) reported that membrane depolarization through L-
type Cav channels and NMDA receptors could enhance neuronal differentiation of adult 
NPCs
15
.  They cultured rat hippocampal NPCs onto primary hippocampal neurons and glia or 
fixed hippocampal cellular substrates under differentiation conditions {excluding mitogens 
and including 2% fetal bovine serum (FBS), 0.5 µM all-trans retinoic acid, 10 µM forskolin 
and 20 ng/ml NT3} for 2 weeks.  Excitatory stimuli {application of 20 mM potassium 
chloride (KCl) or 50 µM glutamate} were then applied to the cultures.  They found that the 
membrane-depolarizing stimuli increased the fraction of NPC progeny which expressed the 
neuronal marker (MAP2ab).  In addition, the excitatory stimuli were sensed by L-type Cav 
channels (especially Cav1.2 and Cav1.3) and NMDA receptors for neuronal differentiation of 
the NPCs.  Furthermore, they observed that membrane depolarization caused changes in gene 
expression in 6 hours; glial fate gene (Hes1 and Id2) expression was down-regulated, and 
neuronal gene (NeuroD) expression was up-regulated.  Similarly, D’Ascenzo et al. reported 
that membrane depolarization promotes neuronal differentiation of cortical NPCs
14
.  They 
cultured neonatal mouse cortex-derived NPCs in the presence of 1% FBS up to 12 days, and 
applied 50 mM KCl to elicit membrane depolarization.  At 0, 3, 6, 9 and 12 days after 
induction of differentiation, they examined phenotypic marker expression, changes in [Ca]i 
and barium (Ba) current density.  They observed that, over the culture period, membrane 
depolarization increased the proportion of cells which expressed neuronal markers, increased 
the amplitude of Ca signal, increased the density of high voltage-activated Ba currents which 
were blocked by nifedipine (5 µM) and increased Cav1.2 expression.  These findings suggest 
that Ca influx through L-type Cav channels is important for induction of neuronal 
differentiation of NPCs.   
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Our results in this study demonstrate that IL-6-induced neuronal differentiation of 
AHPCs is modulated through L-type Cav channels.  We showed that nifedipine or isradipine 
application reduced the percentage of IL-6-induced TuJ1-immunoreactive cells.  Moreover, 
in the culture medium which contained insufficient extracellular calcium, exogenous IL-6 
was unable to enhance neuronal differentiation of AHPCs.  From these results, it is presumed 
that the calcium influx through L-type Cav channels is, at least in part, critical for IL-6-
mediated neuronal differentiation of AHPCs.  
During adult neurogenesis, newborn cells in the dentate gyrus express developmental 
stage-specific phenotypic markers and display electrophysiological characteristics at a given 
time throughout the whole process becoming functional mature neurons in vivo
41
.  At an 
early stage of neuronal differentiation (until ~1 week after cell birth), adult hippocampal 
NPCs are responding to GABA (as an excitatory input) but not to glutamate
41
.  GABA 
excitatory inputs cause an increase in [Ca]i and promote neuronal differentiation
13
.  Later on 
(during the third week after birth), NPC-derived newborn cells receive GABA inhibitory as 
well as glutamate excitatory inputs
41
.  Within the third week, NMDA receptor-dependent 
excitation is known to be important for selective survival/death and synaptogenesis of 
newborn neurons
42
.  Since AHPCs differentiated in the presence of exogenous IL-6 in our 
culture system are presumed to be undergoing an early stage of neuronal differentiation 
(based on the expression of an early neuronal marker and electrophysiological membrane 
properties
1, 2
), it is unlikely that NMDA receptors have a crucial influence in IL-6-induced 
neuronal differentiation during the time window we examined in this study.  Further 
molecular and biophysical characterizations may help to underpin this presumption.       
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CREB activation and neuronal differentiation  
Ca entry can be induced by a variety of stimuli mimicking neuronal activity, such as 
application of neurotransmitters or depolarization of plasma membrane
43
.  The elevation of 
[Ca]i due to extracellular Ca entry then leads rapidly and transiently to transcription of 
immediate early genes
22-24
 which mostly encode transcription factors regulating cellular 
responses to synaptic stimulation during neuritogenesis and synaptic development
24
.  Three 
transcription factors – nuclear factor of activated T-cells (NFAT), and downstream regulatory 
element antagonistic modulator (DREAM) as well as CREB – have been extensively studied 
and are known to be activated though several conceptually different pathways upon [Ca]i 
rise
25, 26
.   
Recently, Jagasia et al. (2009) reported that, in newly generated neurons in adult 
mouse hippocampus, CREB phosphorylation is initiated in ~1-week old postmitotic cells 
after the expression of immature neuronal markers (doublecortin and NeuroD) is initiated
44
.  
They also found that CREB phosphorylation declined ~3-weeks after birth when 
doublecortin or NeuroD expression decreased and the mature dentate granule cell marker 
(calbindin) expression increased
44
.  In addition, the peak of CREB phosphorylation in 
newborn granule cells was paralleled with the timing of membrane depolarization by 
activation of GABAA receptors,which is essential for dendritic morphogenesis of newborn 
cells
45
.  These findings suggest that CREB activation may play a critical role in early 
morphological development and neuronal gene expression in young hippocampal neurons.   
 Considering the consistent observation that pCREB is highly enriched in immature 
hippocampal neurons
44, 46, 47
, our findings showing the increased fraction of pCREB-
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expressing AHPCs in IL-6-treated cultures suggest that IL-6 may accelerates CREB 
phosphorylation during an early stage of AHPC neuronal differentiation.   
 
 
Conclusion 
 IL-6 is an astrocyte-derived factor which promotes neuronal differentiation of AHPCs 
in vitro.  To investigate a possible mechanism of IL-6-mediated neuronal differentiation, we 
examined the influence of L-type Cav channel antagonists and a presence of extracellular 
calcium on IL-6-enhanced neuronal differentiation of AHPCs.  Our immunocytochemical 
results demonstrated that (1) extracellular calcium was necessary for neuronal differentiation 
of IL-6-treated AHPCs, (2) L-type Cav channel antagonists inhibited an increase in the 
fraction of AHPCs expressing a neuronal marker, TuJ1, and (3) IL-6 treatment increased the 
fraction of AHPCs immunoreactive for an activated from of CREB (pCREB).  Taken 
together, our results suggest that IL-6 may induce AHPC differentiation into a neuronal 
lineage by promoting CREB activation which is presumably caused by extracellular calcium 
influx.   
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Figure legends 
 
Figure 1.  Insufficient extracellular calcium prevented IL-6-enhanced neuronal 
differentiation of AHPCs.  AHPCs were cultured in media containing varying concentrations 
of calcium (0.15, 0.25, 0.5 and 1.045 mM) in the presence or absence of IL-6 for 6 days and 
TuJ1-immunoreactivity was then analyzed.  (A) An augmentation of the percentage of TuJ1-
IR AHPCs was observed only in those cultures maintained in a normal calcium concentration 
(1.045 mM).  In the presence of lower calcium concentrations (0.15, 0.25 and 0.5 mM), IL-6 
application had no significant effect on increasing the percentage of TuJ1-IR ACHP.  Results 
were obtained from three independent experiments (N = 3).  (B) Average number of DAPI-
stained cells counted per a unit area (mm
2
) for every culture condition presented in (A).  A 
significantly smaller number of AHPCs were observed in the cultures containing 0.15 mM or 
0.25 mM of external calcium, compared with the culture containing a normal concentration 
of calcium, 1.045 mM).     
           
Figure 2.  L-type Cav channel antagonists, nifedipine and isradipine, specifically inhibited 
neuronal differentiation of AHPCs induced by exogenous IL-6 application.  AHPCs were 
cultured under differentiation conditions for 6 days in the absence or presence of purified rat 
recombinant IL-6 (1 ng/ml).  Without IL-6 treatment, nifedipine or isradipine did not affect 
the fraction of AHPCs expressing TuJ1 nor RIP.  However, in the cultures treated with 
exogenous IL-6, the percentage of TuJ1-IR AHPCs was increased and both nifedipine and 
isradipine reduced the TuJ1-IR fractions with no apparent effect on RIP-IR fractions.  N = 4 
for cultures with dihydropyridines and N = 6 for control cultures.   
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Figure 3.  IL-6 treatment increased the fraction of TuJ1 and pCREB-immunoreactive 
AHPCs.  (A) After 3-day culture session, AHPCs were immunolabeled with anti-CREB or 
anti-pCREB and/or anti-TuJ1.  Approximately 95% AHPCs were CREB-positive regardless 
of IL-6 application.  With IL-6 treatment (‘+ IL-6’ shown in black), the fraction of CREB 
and TUJ1-positive AHPCs was about 3-fold greater than that with no IL-6 added (‘- IL-6’, 
shown in white).  In addition, with IL-6 treatment, the fraction of pCREB-positive AHPCs 
was about 3-fold increased compared to the control.  Moreover, with IL-6 treatment, the 
fraction of pCREB and TuJ1-positive AHPCs was about 9-fold increased compared to the 
control.  Furthermore, when AHPCs were treated with IL-6 and either nifedipine (‘Nif’, 
shown in gray) or IL-6 function blocking antibody (‘Anti-IL-6’, shown in green), IL-6-
induced augmentation of TuJ1 and/or pCREB-positive fractions was not observed.  N = 4 for 
‘- IL-6’ and ‘+ IL-6’; N = 2 for ‘Nif’ and ‘Anti-IL-6’.  (B) Percentage-wise results are 
presented in a ratio-based graph.  Since all TuJ1-positive AHPCs were CREB-positive in all 
culture conditions setup for this experiment, the ratio of %CREB-positive over %TuJ1-
positive (‘CREB+ of TuJ1+’) equals 1.  Because Y-axis for the ratios was expanded to 
display the ratios lower than 0.5 evidently, bars in the graph for ‘CREB+ of TuJ1+’ were cut 
off.  ‘TuJ1+ of CREB+’ represents a portion of AHPCs immunoreactive for TuJ1 within 
CREB-IR fraction.  ‘pCREB+ of TuJ1+’ represents a portion of AHPCs immunoreactive for 
phosphorylated CREB within TuJ1-IR fraction.  ‘TuJ1+ of pCREB+’ represent a portion of 
TuJ1-IR AHPCs within pCREB-IR fraction.  (C) Representative immunofluorescence images 
from designated conditions - cultures with no IL-6 (a and a’) or with IL-6 (b and b’); 
immunolabeling for CREB (a and b) or pCREB (a’ and b’).  Scale bars in a, a’, b and b’ 
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represent 50 µm; ones shown in inset images within Figure a represent 20 µm, which is 
applicable for insets within a’, b and b’ as well.        
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Figure 1.  Insufficient extracellular calcium prevented IL-6-enhanced neuronal 
differentiation of AHPCs.   
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Figure 2.  L-type Cav channel antagonists, nifedipine and isradipine, specifically inhibited 
neuronal differentiation of AHPCs induced by exogenous IL-6 application.   
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Figure 3.  IL-6 treatment increased the fraction of TuJ1 and pCREB-immunoreactive 
AHPCs.   
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Supplementary Figure legends 
 
Supplementary Figure 1.  Extracellular calcium appeared to be important for cell viability.  
After termination of 6-day culture session, AHPCs were stained with propidium iodide (PI) 
to visualize dead cells.  With the lowest concentration of calcium present in culture medium, 
0.15 mM, about one third cells were PI-positive.  N = 2.   
 
Supplementary Figure 2.  IL-6-induced neuronal differentiation was inhibited by nifedipine 
or isradipine.  AHPCs were cultured under differentiation conditions for 6 days in the 
presence of IL-6 (1 ng/ml) with varying concentrations of nifedipine (A) or isradipine (B).  
The percentage of TuJ1-IR AHPCs was about 2-fold increased with IL-6 treatment compared 
to the control (cultures without IL-6 application).  With > 1 µM of nifedipine (A) or > 0.5 
µM of isradipine (B), the fractions of TuJ1-IR AHPCs were significantly decreased 
compared to the control (IL-6-treated cultures without dihydropyridines).  In comparison of 
the percentages of RIP-IR AHPCs, there were no significant changes observed across all 
culture conditions.  N = 3. 
 
Supplementary Figure 3.  IL-6 treatment did not influence RIP and pCREB-
immunoreactivities of AHPCs.  After 3-day culture session, AHPCs were immunolabeled 
with anti-CREB or anti-pCREB and/or anti-RIP.  There was no considerable difference in the 
average percentage of AHPCs immunoreactive for RIP between non-IL-6-treated and IL-6-
treated cultures (RIP-positive fraction: ~11% in control vs ~12% in IL-6-treated condition).  
Almost all AHPCs (~96%) were CREB-positive regardless of IL-6 application.  With and 
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without IL-6 treatment (‘+ IL-6’ presented in black and ‘- IL-6’ shown in white, respectively), 
there was no difference in the percentage of AHPCs immunoreactive for both RIP and CREB.  
In addition, the percentage of AHPCs immunoreactive for both RIP and pCREB in IL-6-
treated cultures was similar to that in non-treated cultures, although the percentage of AHPCs 
immunoreactive only for pCREB was increased in IL-6-treated cultured compared to the 
control cultures (pCREB-positive fraction: ~13% in control vs ~25% in IL-6-trated 
condition).  In IL-6-treated cultures, the fraction of pCREB-positive AHPCs was reduced by 
nifedipine application.  However, the fraction of AHPCs immunoreactive for both RIP and 
pCREB was not affected by nifedipine application.  N = 3 for ‘- IL-6’ and ‘+ IL-6’; N = 2 for 
‘Nif’ and ‘Anti-IL-6’.  
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Supplementary Figure 1.  Extracellular calcium appeared to be important for cell viability.   
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Supplementary Figure 2.  IL-6-induced neuronal differentiation was inhibited by nifedipine 
or isradipine.   
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Supplementary Figure 3.  IL-6 treatment did not influence RIP and pCREB-
immunoreactivities of AHPCs.   
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CHAPTER 5.  
GENERAL CONCLUSIONS 
 
The factors responsible for selective neuronal differentiation of adult neural 
progenitor cells were investigated in vitro.  The results organized in this dissertation 
demonstrate that astrocyte-derived soluble factors specifically promote neuronal 
differentiation of adult hippocampal neural progenitor cells (AHPCs).  In addition, 
interleukin-6 is a neurogenic factor derived from neurogenic astrocytes, and promotes neural 
progenitor cell differentiation into a neuronal lineage.   
As described in the first research chapter (chapter 2), the influence of multiple 
environmental cues (such as, niche cell-derived soluble factors, cell-cell contact, and 
extracellular topography) on AHPC differentiation has been examined in a well-controlled in 
vitro culture system.  Moreover, we have demonstrated that the presence of neonatal 
astrocytes increased AHPC neuronal differentiation and the removal of a physical contact 
between astrocytes and AHPCs further increased neuronal differentiation of AHPCs.  Thus, 
we concluded that soluble factors produced from neonatal astrocytes act as neurogenesis-
promoting cues for AHPCs to commit to a neuronal lineage.  In addition, cellular contact-
mediated interaction between astrocytes and AHPCs appeared to provide a suppressive 
influence on AHPC neuronal differentiation. Moreover, we observed that AHPCs emanated 
significantly longer neurites when cultured without physical contacts with astrocytes on the 
topographically grooved surface compared to those cultured with cellular contacts.  This 
finding also supports a possibility that astrocytes have an activity which suppresses neuronal 
differentiation of AHPCs in a cell-cell contact-dependent manner.  Further studies need to be 
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undertaken to characterize possible mechanism(s) behind the contact-mediated suppression 
of neuronal differentiation.      
In the second research chapter (chapter 3), we further investigated cellular responses 
of AHPCs to astrocyte-derived soluble factors promoting AHPC neuronal differentiation in 
vitro.  To scrutinize a source of neurogenic effects of soluble factors produced from the 
postnatal brain-derived astrocytes.  We have successfully isolated two populations of 
astrocytes from the same brain, hippocampus-derived and cerebral cortex-derived, and 
examined the influences of soluble factors from both astrocyte populations on AHPC 
differentiation by co-culturing AHPCs with astrocytes but without physical contact between 
both cell types.  Our findings showed that soluble factors present in the cultures of 
hippocampus-derived astrocytes and AHPCs dramatically and specifically augmented 
neuronal differentiation of AHPCs.  As well documented, the hippocampus is one of two 
regions where new cells are generated in the postnatal or adult brain and the most of newly 
generated cells are differentiated into hippocampal granule neurons.  Considering that 
astrocytes are the most prevailing cell type in the niche, it was not so surprising that the 
molecules produced and released from hippocampal astrocytes had a profound effect on 
AHPC neuronal differentiation, compared to those from cerebral cortex-derived astrocytes 
did.  Among the numerous molecules produced from neurogenic hippocampal astrocytes, we 
focused on interleukin-6 (IL-6), a neurogenesis-promoting factor.  IL-6 is a pleiotropic 
cytokine which plays a role in both proinflammation and anti-inflammation.  In addition, 
studies examining the role of IL-6 in the neurogenic niches in the brain have proposed to 
exert both neurotoxic and neurotrophic effects in neurogenesis.  In our culture system, an 
exogenous application of IL-6 resulted in the enhancement of AHPC differentiation 
  
173 
preferentially into a neuronal lineage.  Therefore, we concluded that IL-6 derived from 
neurogenic astrocytes is a soluble factor which induces neuronal differentiation of AHPCs.  
Understanding mutual interaction between neural progenitor cells and surrounding cellular 
components by diffusible molecules released in the niche is important to help to develop 
therapeutic strategies to control the fate, proliferation and differentiation of neural progenitor 
cells.  To characterize not only additional astrocyte-derive factors but their combinatorial 
effects, further studies need to be carried out.   
In the last research chapter (chapter 4), possible mechanism(s) by which IL-6 
enhances AHPC neuronal differentiation were investigated.  By culturing AHPCs in either 
low calcium-containing culture medium or voltage-gated calcium channel antagonist-
containing medium in the presence of exogenous IL-6, we examined the influence of 
extracellular calcium on IL-6-enhanced AHPC differentiation.  Our findings using 
immunocytochemical analysis indicate that a presence of extracellular calcium is necessary 
for IL-6 to increase AHPC neuronal differentiation and L-type calcium channel antagonists 
prevent the increase in the fraction of AHPCs which are expressing a neuronal marker.  In 
addition, the fraction of phosphorylated CREB-positive AHPCs was significantly increased 
in IL-6-treated cultures, compared to non-treated cultures.  Thus it is presumed that IL-6-
enhanced neuronal differentiation of AHPCs is mediated by promoting CREB activation 
which is possibly caused by extracellular calcium entry though L-type calcium channels.  
Further molecular and electrophysiological characterizations may need to be performed to 
underpin this presumption.    
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In summary, our findings from the three investigations described in Chapter 2, 3 and 
4 are as follow;  
 AHPC neuronal differentiation (assessed by neuronal marker expression) was 
dramatically increased when AHPCs were co-cultured in physical contact with 
astrocytes. 
 Neuronal differentiation was further increased when physical contact was 
removed from AHPC-astrocyte co-cultures (non-contact co-culture).  
 Under non-contact co-culture conditions, neurite length was significantly greater 
when compared with control (AHPC alone culture) or contact co-culture 
conditions. 
 AHPCs under non-contact co-culture conditions developed membrane properties 
that are consistent with those of differentiated neurons. 
 A candidate for a neurogenic astrocyte-derived soluble factor, IL-6, was produced 
from neurogenic astrocytes.   
 AHPC neuronal differentiation was significantly increased when AHPCs were 
cultured in the presence of exogenous IL-6 compared to the control (cultures 
without IL-6). 
 AHPCs cultured with IL-6 developed a subset of neuronal-like membrane 
properties at an early time point.   
 IL-6-enhanced neuronal differentiation was reduced when AHPCs were cultured 
in low calcium-containing culture medium or with L-type voltage-gated calcium 
channel antagonists. 
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 IL-6 treatment increased the fraction of AHPCs immunoreactive for a neuronal 
marker (TuJ1) and for pCREB. 
 
Taken together, an overall conclusion is that astrocyte-derived soluble factors 
promote neuronal differentiation of adult neural progenitor cells and astrocyte-derived 
interleukin-6 is a neurogenic factor to instruct neural progenitor cells to commit to a neuronal 
lineage.   
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Abstract 
Adult Hippocampal Progenitor Cells (AHPCs; a gift from Fred Gage, Salk Institute, 
La Jolla, CA) are generally maintained in vitro as a dispersed monolayer population of 
multipotent neural progenitors. However little is known about whether cell-cell interactions 
influence their proliferation, differentiation, or migrational activities in vitro, or in vivo 
following transplantation. To investigate possible differences in phenotypic and behavioral 
characteristics, free-floating proliferating cellular aggregates of neurospheres were generated 
from the adherent monolayer population of AHPCs. Both populations of AHPCs 
(neurosphere and adherent) were cultured under differentiation conditions on laminin-coated 
glass coverslips, and their proliferation, phenotypic differentiation and migrational activities 
were compared. AHPC neurospheres displayed a greater percentage of glial marker-
immunoreactive cells (RIP- or GFAP-positive) compared to adherent AHPCs, with no 
significant difference in the percentage of neuronal marker-immunoreactive cells (TuJ1-
positive). In addition, AHPCs emigrating out from neurospheres migrated significantly faster 
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than AHPCs maintained as adherent cells. Our results from in vitro analyses demonstrate that 
AHPCs formed and maintained in neurospheres favored differentiation along a glial lineage 
and displayed greater migrational activity, compared to the adherent population of AHPCs. 
To examine the plasticity of AHPCs from both populations in the central nervous system 
(CNS), we transplanted the GFP-expressing AHPCs via intraocular injection into the eyes of 
postnatal day 1 Fischer 344 rats. Cell survival, morphological differentiation and integration 
were examined at 7, 14 and 28 days after transplantation. At each time point, similar numbers 
of transplanted cells were observed in the cryo-sectioned eyes that received either AHPC 
neurospheres or adherent AHPCs. At the later time points, considerably more cells were 
found integrated into the retina, often with highly branched processes. These findings 
demonstrate that both AHPC populations (neurosphere and adherent) are capable of 
surviving and integrating into the developing host CNS. Taken together, these results suggest 
that cell-cell interactions during AHPC maintenance may influence cell fate under 
differentiation conditions. Moreover, transplanted AHPCs display considerable plasticity in 
the developing CNS.  
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